John Julian Fung

Q: What Schools Are Affiliated With John Julian Fung

John Julian Fung is affiliated with the following schools: University of Chicago, University of Pittsburgh, King's College, Aberdeen

John Julian Fung's AcademicInfluence.com Rankings

John Julian Fung

Philosophy

#3730

World Rank

#5974

Historical Rank

Logic

#1365

World Rank

#2098

Historical Rank

philosophy Degrees

John Julian Fung

Biology

#4714

World Rank

#7005

Historical Rank

Immunology

#210

World Rank

#219

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Why Is John Julian Fung Influential?

(Suggest an Edit or Addition)

(See a Problem?)

John Julian Fung's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Banff schema for grading liver allograft rejection: An international consensus document (1997) (1152)
Cell migration and chimerism after whole‐organ transplantation: The basis of graft acceptance (1993) (808)
FK 506 FOR LIVER, KIDNEY, AND PANCREAS TRANSPLANTATION (1989) (791)
Orthotopic liver transplantation for patients with hepatitis B virus–related liver disease (1991) (520)
Liver Transplantation in the United States, 1999–2008 (2010) (517)
Tolerogenic immunosuppression for organ transplantation (2003) (493)
Long-Term Survival After Liver Transplantation in 4,000 Consecutive Patients at a Single Center (2000) (489)
Epstein-barr virus-induced posttransplant lymphoproliferative disorders (1999) (475)
Murine liver allograft transplantation: Tolerance and donor cell chimerism (1994) (469)
The Incidence, Timing, and Management of Biliary Tract Complications After Orthotopic Liver Transplantation (1994) (467)
Immunosuppression: Evolution in Practice and Trends, 1994–2004 (2006) (435)
Weaning of immunosuppression in liver transplant recipients. (1997) (413)
Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. (1999) (406)
Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. (1996) (387)
Experience With Liver And Kidney Allografts From Non‐Heart-Beating Donors (1995) (355)
Clinical Intestinal Transplantation: A Decade of Experience at a Single Center (2001) (340)
Baboon-to-human liver transplantation (1993) (331)
Acute liver failure: Clinical features, outcome analysis, and applicability of prognostic criteria (2000) (331)
2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody‐Mediated Rejection (2016) (330)
Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. (1997) (315)
Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity? (2000) (304)
Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. (1998) (297)
Medically Necessary, Time-Sensitive Procedures: Scoring System to Ethically and Efficiently Manage Resource Scarcity and Provider Risk During the COVID-19 Pandemic (2020) (293)
Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial (2012) (275)
Consensus Document: Therapeutic Monitoring of Tacrolimus (FK‐506) (1995) (273)
Near-total human face transplantation for a severely disfigured patient in the USA (2009) (263)
HUMAN ISLET ISOLATION AND ALLOTRANSPLANTATION IN 22 CONSECUTIVE CASES 1, 2 (1992) (257)
Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. (1996) (255)
Zygomycosis in Solid Organ Transplant Recipients in a Tertiary Transplant Center and Review of the Literature (2006) (253)
Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management (2003) (251)
Pancreatic islet transplantation after upper abdominal exeriteration and liver replacement (1990) (243)
Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. (1998) (239)
Influenza Virus Infection in Adult Solid Organ Transplant Recipients (2002) (233)
The spectrum of portal vein thrombosis in liver transplantation. (1991) (231)
Liver, Kidney, and Thoracic Organ Transplantation Under FK 506 (1990) (224)
FK 506 for human liver, kidney, and pancreas transplantation (1989) (223)
Immunological quantitation and localization of ACAT-1 and ACAT-2 in human liver and small intestine. (2000) (222)
Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting. (1999) (222)
Pregnancy after liver transplantation under tacrolimus. (1997) (219)
Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. (1995) (217)
Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver disease (2006) (216)
Effect of donor age and sex on the outcome of liver transplantation. (1995) (209)
A randomized trial of inhaled cyclosporine in lung-transplant recipients. (2006) (207)
Posttransplant Lymphoproliferative Disorders in Liver Transplantation: A 20-Year Experience (2002) (205)
The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: A pilot study (1997) (205)
Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony- stimulating factor (1995) (204)
Pathophysiologic Observations and Histopathologic Recognition of the Portal Hyperperfusion or Small-for-Size Syndrome (2006) (200)
Pseudallescheria boydii (Anamorph Scedosporium apiospermum) Infection in Solid Organ Transplant Recipients in a Tertiary Medical Center and Review of the Literature (2002) (199)
Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection (2012) (198)
Neurologic complications of FK 506. (1991) (196)
De novo malignancies after liver transplantation: A major cause of late death (2001) (193)
Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. (1998) (192)
Adverse effects associated with the use of FK 506. (1991) (190)
Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center’s experience update at 13 years1 (2003) (189)
The many faces of multivisceral transplantation. (1991) (185)
Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation. (1992) (183)
Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. (1997) (181)
Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath. (2005) (176)
Influence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: effect of correction of donor hypernatremia. (1999) (174)
First U.S. Near-Total Human Face Transplantation: A Paradigm Shift for Massive Complex Injuries (2010) (172)
Infectivity of hepatic allografts with antibodies to hepatitis B virus. (1997) (167)
Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. (1999) (166)
Liver transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence. (2001) (163)
Robotic versus laparoscopic resection of liver tumours. (2010) (161)
Cryptococcosis in Organ Transplant Recipients: An Overview (2002) (161)
Orthotopic liver transplantation in patients with human immunodeficiency virus and end‐stage liver disease (2003) (161)
Logistics and Technique for Procurement of Intestinal, Pancreatic, and Hepatic Grafts From the Same Donor (2000) (161)
Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts. (1999) (160)
Survival of Liver Transplant Patients Coinfected with HIV and HCV Is Adversely Impacted by Recurrent Hepatitis C (2006) (157)
Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors. (1999) (157)
Renal Function at Two Years in Liver Transplant Patients Receiving Everolimus: Results of a Randomized, Multicenter Study (2013) (156)
In vivo immune modulatory activity of hepatic stellate cells in mice (2006) (155)
Assessment of five-year experience with abdominal organ cluster transplantation. (1995) (153)
Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation. (1993) (152)
The antibody crossmatch in liver transplantation. (1986) (151)
Weaning Of Immunosuppression In Long‐Term Liver Transplant Recipients (1995) (150)
CADAVERIC SMALL BOWEL AND SMALL BOWEL‐LIVER TRANSPLANTATION IN HUMANS 1,2 (1992) (149)
Prolongation of cardiac allograft survival using dendritic cells treated with NF-kB decoy oligodeoxyribonucleotides. (2000) (148)
Post‐liver transplantation sarcopenia in cirrhosis: A prospective evaluation (2014) (146)
Tacrolimus (FK 506)--a new therapeutic agent for severe recalcitrant psoriasis. (1992) (146)
Use of Alemtuzumab and Tacrolimus Monotherapy for Cadaveric Liver Transplantation: With Particular Reference to Hepatitis C Virus (2004) (145)
Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect? (1988) (145)
FK506 “RESCUE” FOR RESISTANT REJECTION OF RENAL ALLOGRAFTS UNDER PRIMARY CYCLOSPORINE IMMUNOSUPPRESSION1 (1994) (139)
Interferon-α for prophylaxis of recurrent viral hepatitis C in liver transplant recipients : A prospective, randomized, controlled trial (1998) (139)
Clinical intestinal transplantation: new perspectives and immunologic considerations. (1998) (139)
Three years clinical experience with intestinal transplantation. (1994) (137)
Non-lymphoid cancer after liver transplantation. (1997) (137)
A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C (2002) (136)
Marked Prolongation of Cardiac Allograft Survival by Dendritic Cells Genetically Engineered with NF-κB Oligodeoxyribonucleotide Decoys and Adenoviral Vectors Encoding CTLA4-Ig1 (2002) (135)
Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation. (1995) (133)
Pharmacokinetics of FK 506: preclinical and clinical studies. (1990) (132)
FK 506 in clinical kidney transplantation. (1991) (131)
Hepatic resection and transplantation for peripheral cholangiocarcinoma. (1997) (130)
Management of splenic artery aneurysms: the significance of portal and essential hypertension. (1999) (130)
Cryptococcal meningitis: an analysis among 5521 consecutive organ transplant recipients (2002) (130)
Themes of liver transplantation (2010) (130)
肝,腎,およびすい臓移植のためのFK506 (1989) (129)
Systemic administration of cellular interleukin-10 can exacerbate cardiac allograft rejection in mice. (1996) (129)
Pediatric liver transplantation. A single center experience spanning 20 years. (2002) (127)
Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcome. (2000) (124)
Pretransplant survival is shorter in HIV‐positive than HIV‐negative subjects with end‐stage liver disease (2005) (123)
Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice (2011) (123)
International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients. (2018) (123)
Evolution of hepatitis B virus liver disease after hepatic replacement. Practical and theoretical considerations. (1990) (122)
SPLIT TOLERANCE INDUCED BY ORTHOTOPIC LIVER TRANSPLANTATION IN MICE1 (1994) (121)
Renal transplantation in recipients over the age of 60: the impact of donor age. (1999) (121)
Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation (2000) (120)
THE ADVERSE IMPACT ON LIVER TRANSPLANTATION OF USING POSITIVE CYTOTOXIC CROSSMATCH DONORS 1, 2 (1992) (118)
The side effects of FK 506 in humans. (1990) (115)
The Association of Center Performance Evaluations and Kidney Transplant Volume in the United States (2013) (115)
Cytomegalovirus PP65 antigenemia monitoring as a guide for preemptive therapy: a cost effective strategy for prevention of cytomegalovirus disease in adult liver transplant recipients. (1999) (114)
WEANING OF IMMUNOSUPPRESSION IN LONG-TERM LIVER TRANSPLANT RECIPIENTS (1995) (114)
A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies (1992) (114)
A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients. (1999) (113)
An Analysis of Early Renal Transplant Protocol Biopsies – the High Incidence of Subclinical Tubulitis (2001) (113)
Liver-Derived DEC205+B220+CD19− Dendritic Cells Regulate T Cell Responses1 (2001) (113)
Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors (2012) (112)
The clinical trial of FK 506 as primary and rescue immunosuppression in adult cardiac transplantation. (1991) (111)
CONVERSION OF LIVER ALLOGRAFT RECIPIENTS FROM CYCLOSPORINE TO FK506 IMMUNOSUPPRESSIVE THERAPY—A CLINICOPATHOLOGIC STUDY OF 96 PATIENTS (1992) (110)
THE EFFECT OF GRAFT FUNCTION ON FK506 PLASMA LEVELS, DOSAGES, AND RENAL FUNCTION, WITH PARTICULAR REFERENCE TO THE LIVER (1991) (110)
The development and compensation of biliary cirrhosis in interleukin-6-deficient mice. (2000) (109)
A prospective randomized trial of FK506-based immunosuppression after renal transplantation. (1995) (109)
The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients (2002) (109)
Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection. (2002) (109)
Central nervous system lesions in liver transplant recipients: prospective assessment of indications for biopsy and implications for management. (1998) (108)
SMALL INTESTINAL TRANSPLANTATION IN HUMANS WITH OR WITHOUT THE COLON1,2 (1994) (108)
In vivo effect of FK506 on human pancreatic islets. (1991) (107)
Predicting Outcomes After Liver Transplantation A Connectionist Approach (1994) (107)
Analysis of chronic rejection and obliterative arteriopathy. Possible contributions of donor antigen-presenting cells and lymphatic disruption. (1997) (107)
Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations. (1990) (106)
Split-liver transplantation: a comparison of ex vivo and in situ techniques. (2000) (105)
Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients. (1997) (105)
Tacrolimus rescue therapy for renal allograft rejection--five-year experience. (1997) (105)
The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation. (1996) (104)
Early events in liver allograft rejection. Delineation of sites of simultaneous intragraft and recipient lymphoid tissue sensitization. (1991) (103)
Liver allograft rejection: an overview of morphologic findings. (1990) (102)
Kidney Transplantation Under a Tolerogenic Regimen of Recipient Pretreatment and Low-Dose Postoperative Immunosuppression With Subsequent Weaning (2003) (102)
Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. (1998) (102)
Ethical considerations and rationale of adult‐to‐adult living donor liver transplantation (2001) (101)
Brain abscess in solid organ transplant recipients receiving cyclosporine-based immunosuppression. (1997) (100)
PD‐1/B7‐H1 Interaction Contribute to the Spontaneous Acceptance of Mouse Liver Allograft (2010) (100)
Porcine partial liver transplantation: A novel model of the “small‐for‐size” liver graft (2004) (100)
Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody. (1997) (100)
Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis (2002) (100)
Tobacco use following liver transplantation for alcoholic liver disease: An underestimated problem (2005) (99)
Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21(WAF1/Cip1) as a disease marker and the influence of immunosuppressive drugs. (2001) (99)
Sanguineous normothermic machine perfusion improves hemodynamics and biliary epithelial regeneration in donation after cardiac death porcine livers (2014) (99)
Recurrent hepatitis C after liver transplantation: A nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin (2001) (99)
A PROSPECTIVE RANDOMIZED TRIAL COMPARING SEQUENTIAL GANCICLOVIR‐HIGH DOSE ACYCLOVIR TO HIGH DOSE ACYCLOVIR FOR PREVENTION OF CYTOMEGALOVIRUS DISEASE IN ADULT LIVER TRANSPLANT RECIPIENTS (1994) (98)
Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients. (1996) (98)
A high incidence of native portal vein thrombosis in veterans undergoing liver transplantation. (1996) (97)
Liver transplantation in patients with liver metastases from neuroendocrine tumors: A systematic review (2017) (97)
Long-term results after liver transplantation for primary hepatic epithelioid hemangioendothelioma (1995) (96)
Myeloid-Derived Suppressor Cells Protect Islet Transplants by B7-H1 Mediated Enhancement of T Regulatory Cells (2012) (95)
TACROLIMUS AND TRANSPLANTATION: A DECADE IN REVIEW (2004) (94)
Dental health status of liver transplant candidates (2007) (94)
Orthotopic liver transplantation in high-risk patients: risk factors associated with mortality and infectious morbidity. (1998) (94)
Hepatic artery angioplasty after liver transplantation: experience in 21 allografts. (1995) (94)
Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study (2015) (93)
Early death or retransplantation in adults after orthotopic liver transplantation. Can outcome be predicted? (1994) (93)
The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells. (2013) (93)
Protecting the Kidney in Liver Transplant Recipients: Practice‐Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice (2016) (92)
Incentives for Organ Donation: Proposed Standards for an Internationally Acceptable System (2012) (92)
Thrombotic and nonthrombotic hepatic artery complications in adults and children following primary liver transplantation with long‐term follow‐up in 1000 consecutive patients * (2006) (92)
Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome. (1997) (91)
Hepatic Stellate Cells Preferentially Expand Allogeneic CD4+CD25+FoxP3+ Regulatory T Cells in an IL-2-Dependent Manner (2008) (90)
Prevention of diabetes in NOD mice by administration of dendritic cells deficient in nuclear transcription factor-kappaB activity. (2003) (90)
Immunopathology of antibodies as effectors of orthotopic liver allograft rejection. (1992) (90)
A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients: an interim report. (1998) (89)
New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients. (1991) (88)
Combined liver-kidney transplantation: analysis of patients with preformed lymphocytotoxic antibodies. (1988) (88)
Pharmacokinetics of Mycophenolic Acid after Mycophenolate Mofetil Administration in Liver Transplant Patients Treated with Tacrolimus (2001) (87)
Liver transplantation for Wilson's disease: a single-center experience. (1999) (86)
COMPARATIVE LONG-TERM EVALUATION OF TACROLIMUS AND CYCLOSPORINE IN PEDIATRIC LIVER TRANSPLANTATION (2000) (86)
Intestinal transplantation: a coming of age. (2002) (85)
Recurrent Hepatitis C in Liver Allografts: Prospective Assessment of Diagnostic Accuracy, Identification of Pitfalls, and Observations About Pathogenesis (2004) (85)
Immunosuppression in liver transplantation: Beyond calcineurin inhibitors (2005) (84)
Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts. (1997) (84)
Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. (1990) (84)
The influence of hepatitis C virus genotypes on the outcome of liver transplantation. (1998) (83)
Liver transplantation in patients over sixty years of age. (2001) (83)
Dynamic behavior of hepatitis C virus in chronically infected patients receiving liver graft from infected donors. (1996) (83)
Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in liver transplantation patients (2003) (82)
Intrahepatic biliary anatomy of living adult liver donors: correlation of mangafodipir trisodium-enhanced MR cholangiography and intraoperative cholangiography. (2002) (82)
Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb. (1999) (81)
Intraindividual and Interindividual Variations in the Pharmacokinetics of Mycophenolic Acid in Liver Transplant Patients (2005) (81)
Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. (1993) (81)
Adverse effects of FK 506 overdosage after liver transplantation. (1993) (80)
Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow‐up of 6 years (2001) (80)
Molecular Basis of Evolutionary Loss of the α1,3-Galactosyltransferase Gene in Higher Primates* (2002) (80)
Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine. (1991) (80)
Sirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimus. (2001) (79)
Efficacy of FK 506 in the treatment of recalcitrant pyoderma gangrenosum. (1991) (79)
The effects of FK 506 on renal function after liver transplantation. (1990) (78)
Early trials with FK 506 as primary treatment in liver transplantation. (1990) (77)
Pediatric renal transplantation under tacrolimus-based immunosuppression. (1998) (77)
Caroli's disease and orthotopic liver transplantation (2006) (76)
Activation of the lipopolysaccharide signaling pathway in hepatic transplantation preservation injury12 (2002) (75)
Should HLA Mismatch Acceptability for Sensitized Transplant Candidates Be Determined at the High‐Resolution Rather Than the Antigen Level? (2015) (75)
SUPPRESSION OF ALLOGRAFT REJECTION WITH FK506: I. PROLONGED CARDIAC AND LIVER SURVIVAL IN RATS FOLLOWING SHORT‐COURSE THERAPY (1990) (75)
De Novo Sirolimus and Reduced‐Dose Tacrolimus Versus Standard‐Dose Tacrolimus After Liver Transplantation: The 2000–2003 Phase II Prospective Randomized Trial (2014) (74)
Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation (2003) (73)
Kidney transplantation under FK 506 immunosuppression. (1991) (73)
MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates. (2010) (73)
Hepatic Resection and Transplantation for Peripheral Cholangiocarcinoma (1997) (72)
Abdominal Multivisceral Transplantation (1995) (71)
Pregnancy after kidney and kidney-pancreas transplantation under tacrolimus: a single center’s experience (2004) (71)
IL-12 Antagonism Enhances Apoptotic Death of T Cells Within Hepatic Allografts from Flt3 Ligand-Treated Donors and Promotes Graft Acceptance1 (2001) (70)
Laparoscopic versus open resection of colorectal liver metastasis (2013) (70)
Infectious complications after small bowel transplantation in adults: an update. (1996) (69)
Blockade of tryptophan catabolism prevents spontaneous tolerogenicity of liver allografts. (2001) (69)
Influence of donor cardiopulmonary arrest in human liver transplantation: Possible role of ischemic preconditioning (2000) (69)
Cytokine Mrna Profiles In Mouse Orthotopic Liver Transplantation Graft Rejectionis Associasted With Augmented Th1 Function (1995) (69)
Comparative study of cyclosporine and FK 506 dosage requirements in adult and pediatric orthotopic liver transplant patients. (1991) (68)
Cryptococcal meningitis after liver transplantation. (1996) (68)
Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: long-term follow-up and evaluation of features for histopathological staging. (2000) (68)
The Biological Basis of and Strategies for Clinical Xenotransplantation (1994) (68)
Allospecificity of activated T cells grown from endomyocardial biopsies from heart transplant patients. (1986) (66)
Rituximab (Chimeric Anti-CD20 Antibody) for Posttransplant Lymphoproliferative Disorder after Solid Organ Transplantation in Adults: Long-Term Experience from a Single Center (2005) (66)
Prevention and treatment of cytomegalovirus infection in organ transplant recipients (1999) (65)
Progressive primary sclerosing cholangitis requiring liver transplantation is associated with reduced need for colectomy in patients with ulcerative colitis. (2012) (65)
Ex Vivo Normothermic Machine Perfusion Is Safe, Simple, and Reliable (2015) (64)
Liver and kidney transplantation from non-heart beating donors: the Pittsburgh experience. (1995) (63)
Primary tacrolimus (FK506) therapy and the long‐term risk of post‐transplant lymphoproliferative disease in pediatric liver transplant recipients (2001) (63)
Lymphoma resembling hodgkin disease after posttransplant lymphoproliferative disorder in a liver transplant recipient (1993) (63)
Comparison of laparoscopic versus open liver tumor resection: a case-controlled study (2009) (63)
Causes of retransplantation after primary liver transplantation in 4000 consecutive patients: 2 to 19 years follow-up. (2001) (63)
Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. (1991) (63)
Five Cases of Fulminant Hepatitis Due to Herpes Simplex Virus in Adults (2002) (63)
Randomised trialomania? The multicentre liver transplant trials of tacrolimus (1995) (62)
Interferon-alpha for prophylaxis of recurrent viral hepatitis C in liver transplant recipients: a prospective, randomized, controlled trial. (1998) (62)
Central venulitis in the allograft liver: a clinicopathologic study. (1997) (62)
Hepatocellular carcinomas in native livers from patients treated with orthotopic liver transplantation: Biologic and therapeutic implications (2001) (62)
Functional characterization of infiltrating T lymphocytes in human hepatic allografts. (1986) (62)
IMMUNOMODULATION FOR INTESTINAL TRANSPLANTATION BY ALLOGRAFT IRRADIATION, ADJUNCT DONOR BONE MARROW INFUSION, OR BOTH1 (2000) (61)
Bacterial translocation in clinical intestinal transplantation. (2001) (61)
FK 506: a new therapeutic agent for severe recalcitrant psoriasis. (1991) (60)
Lessons of organ-induced tolerance learned from historical clinical experience. (2004) (59)
Hepatic resection in 170 patients using saline-cooled radiofrequency coagulation. (2005) (59)
Ribavirin dose modification based on renal function is necessary to reduce hemolysis in liver transplant patients with hepatitis C virus infection (2002) (59)
Initial experience using histidine‐tryptophan‐ketoglutarate solution in clinical pancreas transplantation * (2004) (58)
Acute respiratory failure associated with pulmonary cryptococcosis in non-aids patients. (2001) (58)
Adenosine restores the hepatic artery buffer response and improves survival in a porcine model of small‐for‐size syndrome (2009) (58)
Time to detection of cytomegalovirus (CMV) DNA in blood leukocytes is a predictor for the development of CMV disease in CMV-seronegative recipients of allografts from CMV-seropositive donors following liver transplantation. (1996) (58)
Myeloid-Derived Suppressor Cells as a Potential Therapy for Experimental Autoimmune Myasthenia Gravis (2014) (58)
Reversibility of pulmonary hypertension after liver transplantation: a case report. (1993) (58)
Hepatotrophic effects of FK506 in dogs. (1991) (57)
Liver transplantation for unresectable colorectal liver metastases: A systematic review (2017) (57)
Prognostic Value of Abdominal CT Scanning and Hepatic Histopathology in Patients with Acute Liver Failure (2000) (57)
Guidance of ganciclovir therapy with pp65 antigenemia in cytomegalovirus-free recipients of livers from seropositive donors. (1996) (56)
Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies. (1994) (56)
Comparing Normothermic Machine Perfusion Preservation With Different Perfusates on Porcine Livers From Donors After Circulatory Death (2016) (56)
TREATMENT OF CYCLOSPORIN-INDUCED HAEMOLYTIC URAEMIC SYNDROME WITH FK506 (1989) (56)
Living-Related Donor Renal Transplantation in HIV+ Recipients using Alemtuzumab Preconditioning and Steroid-Free Tacrolimus Monotherapy: A Single Center Preliminary Experience (2004) (55)
Human Hepatic Stellate Cells Inhibit T-Cell Response Through B7-H1 Pathway (2013) (55)
Liver transplantation in patients with HIV infection (2004) (55)
Survival and quality of life after liver transplantation for acute alcoholic hepatitis. (1997) (55)
Nelfinavir, a protease inhibitor, increases sirolimus levels in a liver transplantation patient: A case report (2002) (55)
Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression. (2000) (55)
Immunoglobulin g lymphocytotoxic antibodies in clinical liver transplantation: Studies toward further defining their significance (1995) (55)
In vitro propagation and homing of liver-derived dendritic cell progenitors to lymphoid tissues of allogeneic recipients. Implications for the establishment and maintenance of donor cell chimerism following liver transplantation. (1995) (55)
Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506. (1991) (54)
INTERFERON-a FOR PROPHYLAXIS OF RECURRENT VIRAL HEPATITIS C IN LIVER TRANSPLANT RECIPIENTS (1998) (54)
Experience with liver and kidney allografts from non-heart-beating donors. (1995) (54)
OUTCOME AFTER STEROID WITHDRAWAL IN PEDIATRIC RENAL TRANSPLANT PATIENTS RECEIVING TACROLIMUS-BASED IMMUNOSUPPRESSION1 (1999) (54)
Prolongation of Cardiac Allograft Survival by Systemic Administration of Immature Recipient Dendritic Cells Deficient in NF-κB Activity (2005) (54)
Stearoyl-CoA desaturase plays an important role in proliferation and chemoresistance in human hepatocellular carcinoma. (2014) (53)
The Cleveland Clinic FACES Score: A Preliminary Assessment Tool for Identifying the Optimal Face Transplant Candidate (2009) (53)
LONG-TERM RESULTS OF PANCREAS TRANSPLANTATION UNDER TACROLIMUS IMMUNOSUPPRESSION (1998) (53)
Hyperbaric oxygen therapy for hepatic artery thrombosis after liver transplantation in children. (1999) (53)
Role of Splenectomy in Human Liver Transplantation Under Modern-Day Immunosuppression (1998) (53)
The efficacy of daclizumab for intestinal transplantation: preliminary report. (1999) (53)
Clinical outcome of patients infected with hepatitis C virus infection on survival after primary liver transplantation under tacrolimus. (1998) (52)
Transjugular intrahepatic portosystemic shunt in patients with end-stage liver disease: results in 85 patients. (1996) (52)
Liver allograft rejection in sensitized recipients. Observations in a clinically relevant small animal model. (1993) (52)
Clinical intestinal transplantation: a decade of a single center experience (2001) (52)
The 11 ‐year pittsburgh experience with liver transplantation for hepatocellular carcinoma: 1981‐1991 (1993) (51)
Late-onset renal failure after liver transplantation: role of posttransplant alcohol use. (2000) (50)
Immunosuppression for liver transplantation in HCV‐infected patients: Mechanism‐based principles (2005) (50)
Alemtuzumab Induction and Tacrolimus Monotherapy in Pancreas Transplantation: One- and Two-Year Outcomes (2006) (50)
Real-time monitoring of acute liver-allograft rejection using the Banff schema. (2002) (50)
The quandary over liver transplantation for hepatocellular carcinoma: The greater sin? (2002) (50)
Risks and benefits of weaning immunosuppression in liver transplant recipients: long-term follow-up. (1997) (49)
Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis1 (2002) (49)
PREVENTION OF GRAFT‐VERSUS‐HOST DISEASE FOLLOWING ALLOGENEIC BONE MARROW TRANSPLANTATION IN RATS USING FK506 (1991) (49)
EVIDENCE FOR EARLY Th 2 T CELL PREDOMINANCE IN XENOREACTIVITY (1993) (49)
Reversal of acute cellular rejection after renal transplantation with Campath-1H. (2005) (49)
FK506 in Solid Organ Transplantation (1995) (49)
Weaning of immunosuppression in long-term recipients of living related renal transplants: a preliminary study. (1995) (49)
Influence of Cold Ischemia Time and Graft Transport Distance on Postoperative Outcome in Human Liver Transplantation (2002) (48)
The pathogenesis and management of influenza virus infection in organ transplant recipients (2002) (48)
Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis. (2017) (48)
Real-time monitoring of acute liver-allograft rejection using the Banff schema1 (2002) (48)
Gastrointestinal bleeding after liver transplantation. (1997) (48)
Flexible Management of Enzymatic Digestion Improves Human Islet Isolation Outcome from Sub‐Optimal Donor Pancreata (2003) (48)
Pharmacokinetics of FK506 in Liver Transplant Recipients After Continuous Intravenous Infusion (1993) (48)
Lipid metabolism and functional assessment of discarded human livers with steatosis undergoing 24 hours of normothermic machine perfusion (2018) (47)
Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity. (1998) (47)
Fungal infection in liver transplantation. (2002) (47)
Incidence and severity of acute allograft rejection in liver transplant recipients treated with alfa interferon. (1998) (46)
A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone and mycophenolate mofetil in primary adult liver transplantation: a single center report. (2001) (46)
Successful sequential liver-kidney transplantation in a patient with performed lymphocytotoxic antibodies. (1987) (45)
Quantitation of Immunosuppression by Tacrolimus Using Flow Cytometric Analysis of Interleukin-2 and Interferon-&ggr; Inhibition in CD8− and CD8+ Peripheral Blood T Cells (2001) (45)
Longitudinal study of cryptococcosis in adult solid‐organ transplant recipients (2003) (45)
Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from FLT3L-treated donors. (2001) (45)
Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival (2003) (45)
Measurement of CD4+ T‐cell function in predicting allograft rejection and recurrent hepatitis C after liver transplantation (2010) (45)
Effects of donor bone marrow infusion in clinical lung transplantation. (2000) (45)
Pathologic observations in human allograft recipients treated with FK 506. (1990) (45)
"Suboptimal" kidney donors: the experience with tacrolimus-based immunosuppression. (1996) (44)
Resolution of Severe Pyoderma Gangrenosum in a Patient with Streaking Leukocyte Factor Disease after Treatment with Tacrolimus (FK 506) (1993) (44)
A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients. (1995) (44)
The question of FK 506 nephrotoxicity after liver transplantation. (1991) (43)
In vitro propagation and homing of liver-derived dendritic cell progenitors to lymphoid tissues of allogeneic recipients (1994) (43)
Disease gravity and urgency of need as guidelines for liver allocation (1994) (43)
Liver transplantation under tacrolimus in infants, children, adults, and seniors: long-term results, survival, and adverse events in 1000 consecutive patients. (1998) (43)
Posttransplant lymphoproliferative disorders occurring under primary FK 506 immunosuppression. (1991) (43)
Monitoring and treatment of intestinal allograft rejection in humans. (1993) (42)
Changes in renal function after liver transplantation under FK 506. (1991) (42)
Combined Liver-Kidney Transplants: Allosensitization and Recipient Outcomes (2011) (42)
Monitoring the patient off immunosuppression. Conceptual framework for a proposed tolerance assay study in liver transplant recipients. (2001) (42)
Synergistic effect of cold and warm ischemia time on postoperative graft function and outcome in human liver transplantation. (2004) (42)
Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients. (1998) (42)
Primary adult liver transplantation under tacrolimus: more than 90 months actual follow-up survival and adverse events. (1999) (42)
All-trans Retinoic Acid Induces Arginase-1 and Inducible Nitric Oxide Synthase–Producing Dendritic Cells with T Cell Inhibitory Function (2014) (42)
Distinct response of liver myeloid dendritic cells to endotoxin is mediated by IL-27. (2009) (42)
Tacrolimus in pediatric renal transplantation. (1996) (42)
Infusion of donor leukocytes to induce tolerance in organ allograft recipients (1999) (42)
Invasive aspergillosis in liver transplant recipients: outcome comparison of therapy with amphotericin B lipid complex and a historical cohort treated with conventional amphotericin B. (2003) (42)
Impact of Orthoclone OKT3 on liver transplantation. (1987) (42)
Expessive dysphasia possibly related to FK506 in two liver transplant recipients (1990) (41)
Interactions between bronchoalveolar lymphocytes and macrophages in heart-lung transplant recipients. (1985) (41)
FK 506 conversion of renal allografts failing cyclosporine immunosuppression. (1991) (41)
Pancreas Transplantation Under Alemtuzumab (Campath-1H) and Tacrolimus: Correlation Between Low T-Cell Responses and Infection (2006) (41)
Improved surgical technique for the establishment of a murine model of aortic transplantation (1998) (41)
The impact of positive T-cell lymphocytotoxic crossmatch on intestinal allograft rejection and survival. (2000) (41)
Minimal Evidence of Transdifferentiation from Recipient Bone Marrow to Parenchymal Cells in Regenerating and Long‐Surviving Human Allografts (2003) (41)
Isolation of Human Islets for Autologous Islet Transplantation in Children and Adolescents with Chronic Pancreatitis (2012) (40)
Combined heart and liver transplantation: the Cleveland Clinic experience. (2013) (40)
Association between donor‐recipient serum sodium differences and orthotopic liver transplant graft function (2008) (40)
Outcome of liver transplantation using donors 60 to 79 years of age. (1995) (40)
Replacement of donor lymphoid tissue in human small bowel transplants under FK 506 immunosuppression (1991) (40)
Assay of FK 506 in plasma. (1990) (40)
Temporary withdrawal of immunosuppression for life-threatening infections after liver transplantation. (1994) (40)
Experience with posttransplant lymphoproliferative disorders in solid organ transplant recipients. (1992) (40)
Conversion to neoral for neurotoxicity after primary adult liver transplantation under tacrolimus. (2000) (40)
Posttransplant lymphoproliferative disorders in small bowel allograft recipients. (2000) (40)
Does Transjugular Intrahepatic Portosystemic Shunt (TIPS) Resolve Thrombocytopenia Associated with Cirrhosis? (1998) (40)
Use of DNA amplification for diagnosis of cytomegalovirus enteritis after intestinal transplantation. (1997) (39)
Use of OKT3 with Ciclosporin and Steroids for Reversal of Acute Kidney and Liver Allograft Rejection (1987) (39)
Combined veno-venous bypass and high volume hemofiltration during orthotopic liver transplantation. (1993) (39)
Simultaneous administration of adjuvant donor bone marrow in pancreas transplant recipients (1999) (38)
FK506 and pregnancy in liver transplant patients. (1993) (38)
A clinical trial combining donor bone marrow infusion and heart transplantation: intermediate-term results. (2000) (38)
Technical considerations in liver transplantation: What a hepatologist needs to know (and every surgeon should practice) (2005) (38)
Cytokine mRNA profiles in Epstein–Barr virus‐associated post‐transplant lymphoproliferative disorders (1999) (38)
Nutritional management of intestinal transplant recipients. (1993) (38)
Hepatic Stellate Cells Inhibit T Cells through Active TGF-β1 from a Cell Surface–Bound Latent TGF-β1/GARP Complex (2015) (38)
Cotransplantation With Myeloid-Derived Suppressor Cells Protects Cell Transplants: A Crucial Role of Inducible Nitric Oxide Synthase (2014) (37)
Myeloid suppressor cells induced by retinal pigment epithelial cells inhibit autoreactive T-cell responses that lead to experimental autoimmune uveitis. (2012) (37)
Management of intestinal transplantation in humans. (1992) (37)
Triple‐phase computed tomography and intraoperative flow measurements improve the management of portosystemic shunts during liver transplantation (2008) (37)
Portacaval shunt causes apoptosis and liver atrophy in rats despite increases in endogenous levels of major hepatic growth factors. (2002) (36)
Impact of donor age in liver transplantation from donation after circulatory death donors: A decade of experience at Cleveland Clinic (2015) (36)
Causes of death after liver transplantation in 4000 consecutive patients: 2 to 19 year follow-up. (2001) (36)
High-dose cellular IL-10 exacerbates rejection and reverses effects of cyclosporine and tacrolimus in Mouse cardiac transplantation. (1997) (36)
Evidence for the presence of multilineage chimerism and progenitors of donor dendritic cells in the peripheral blood of bone marrow-augmented organ transplant recipients. (1997) (36)
FK 506 in steroid-resistant focal sclerosing glomerulonephritis of childhood (1990) (35)
Mechanistic Insights into Impaired Dendritic Cell Function by Rapamycin: Inhibition of Jak2/Stat4 Signaling Pathway1 (2004) (35)
Acute pancreatitis after liver transplantation: incidence and contributing factors (1995) (35)
Internal hernia and volvulus of the small bowel following liver transplantation (1997) (35)
Is impaired hepatic arterial buffer response a risk factor for biliary anastomotic stricture in liver transplant recipients? (2010) (34)
Tc-99m hexamethylpropylene amine oxime scintigraphy in the diagnosis of brain death and its implications for the harvesting of organs used for transplantation. (2000) (34)
Use of FK 506 in pediatric patients. (1991) (34)
Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression. (1998) (34)
The influence of donor and recipient strains in isolated small bowel transplantation in rats. (1994) (34)
Differential effects of exogenous interleukin-10 on cardiac allograft survival: inhibition of rejection by recipient pretreatment reflects impaired host accessory cell function. (1999) (34)
Altered endothelin homeostasis in patients undergoing liver transplantation. (1996) (33)
The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis1 (2003) (33)
Histopathology of human renal allograft rejection under FK 506: a comparison with cyclosporine. (1991) (33)
Endothelin receptor antagonist TAK-044 arrests and reverses the development of carbon tetrachloride induced cirrhosis in rats (2004) (33)
Association Between Liver Transplant Center Performance Evaluations and Transplant Volume (2014) (33)
Molecular basis of evolutionary loss of the alpha 1,3-galactosyltransferase gene in higher primates. (2002) (32)
Liver transplantation for alcoholic hepatitis in the United States: Excellent outcomes with profound temporal and geographic variation in frequency (2020) (31)
Abrogation of chronic rejection in a murine model of aortic allotransplantation by prior induction of donor-specific tolerance. (1997) (31)
Multicentre results of stereotactic body radiotherapy for secondary liver tumours. (2013) (31)
Piggyback orthotopic intestinal transplantation. (1993) (31)
Comparison of laparoscopic versus open liver tumor resection: a case-controlled study (2009) (31)
PRELIMINARY EXPERIENCE WITH FK506 IN THORACIC TRANSPLANTATION (1991) (31)
De novo breast cancer in patients with liver transplantation: University of Pittsburgh's experience and review of the literature (2004) (31)
Cytomegalovirus infection of the upper gastrointestinal tract following liver transplantation--incidence, location, and severity in cyclosporine- and FK506-treated patients. (1992) (31)
Liver transplant tolerance: Mechanistic insights from animal models, with particular reference to the mouse (1997) (31)
Islet cell allotransplantation in diabetic patients. Histologic findings in four adults simultaneously receiving kidney or liver transplants. (1992) (30)
Efficacy of laparoscopic radiofrequency ablation for the treatment of patients with small solitary colorectal liver metastasis. (2013) (30)
Hemorrhagic Complications of Enoxaparin and Aspirin in Patients with Kidney Transplants (2002) (30)
EBV-specific memory CD8+ T cell phenotype and function in stable solid organ transplant patients. (2005) (30)
Long-Term Outcome of Adding Mycophenolate Mofetil to Tacrolimus for Nephrotoxicity Following Liver Transplantation (2005) (30)
DE NOVO MALIGNANCIES AFTER INTESTINAL AND MULTIVISCERAL TRANSPLANTATION (2004) (30)
Clinical Trials and Projected Future of Liver Xenotransplantation (1997) (30)
An analysis of pretransplantation variables associated with long-term allograft outcome in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. (1998) (30)
Techniques of radiofrequency-assisted precoagulation in laparoscopic liver resection (2011) (30)
Painting factor H onto mesenchymal stem cells protects the cells from complement- and neutrophil-mediated damage. (2016) (29)
REASONS FOR LONG-TERM USE OF STEROID IN PRIMARY ADULT LIVER TRANSPLANTATION UNDER TACROLIMUS12 (2001) (29)
Reduction of primary nonfunction with prostaglandin E1 after clinical liver transplantation. (1995) (29)
The liver transplant waiting list--a single-center analysis. (1991) (29)
EX VIVO GENERATION OF EFFECTIVE EPSTEIN-BARR VIRUS (EBV)-SPECIFIC CD8+ CYTOTOXIC T LYMPHOCYTES FROM THE PERIPHERAL BLOOD OF IMMUNOCOMPETENT EPSTEIN BARR VIRUS-SERONEGATIVE INDIVIDUALS1 (2000) (29)
Dynamics of allospecific T lymphocyte infiltration in vascularized human allografts (1986) (29)
Rejection triggers liver transplant tolerance: Involvement of mesenchyme‐mediated immune control mechanisms in mice (2015) (29)
Autologous Reconstruction and Visceral Transplantation for Management of Patients With Gut Failure After Bariatric Surgery: 20 Years of Experience. (2015) (29)
Randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone after renal transplantation: preliminary report. (1993) (29)
Ex Vivo Priming of Naïve T Cells Into EBV‐Specific Th1/Tc1 Effector Cells by Mature Autologous DC Loaded with Apoptotic/Necrotic LCL (2003) (28)
Tacrolimus for primary liver transplantation: 12 to 15 years actual follow-up with safety profile. (2005) (28)
A prospective, randomized trial to compare tacrolimus and prednisone with and without mycophenolate mofetil in patients undergoing renal transplantation: first report. (1998) (28)
Adenovirus-mediated gene therapy to liver grafts: successful gene transfer by donor pretreatment. (2000) (28)
Hepatic transplantation during pregnancy and the puerperium. (1997) (28)
Incidence of de novo cancer and lymphoproliferative disorders after liver transplantation in relation to age and duration of follow‐up (2008) (28)
The induction of pseudo-graft-versus-host disease following syngeneic bone marrow transplantation using FK 506. (1991) (28)
Complement anaphylatoxin receptors C3aR and C5aR are required in the pathogenesis of experimental autoimmune uveitis (2016) (28)
Split liver transplantation in adults (2016) (28)
Interleukin-2 and interleukin-12 mediate distinct effector mechanisms of liver allograft rejection. (1997) (28)
Infections in adult liver transplant patients under FK 506 immunosuppression. (1991) (28)
Quality of life after intestinal transplantation and on total parenteral nutrition. (1998) (28)
Local Inhibition of Complement Improves Mesenchymal Stem Cell Viability and Function After Administration. (2016) (28)
Hepatitis G virus infection in American patients with cryptogenic cirrhosis: no evidence for liver replication. (1997) (28)
Adult respiratory distress syndrome secondary to end-stage liver disease-successful outcome following liver transplantation. (1993) (27)
Chimerism after organ transplantation (1997) (27)
Hemodynamic effects of inhaled nitric oxide in four patients with severe liver disease and pulmonary hypertension. (1997) (27)
Tacrolimus Analysis: A Comparison of Different Methods and Matrices (1995) (27)
Liver transplantation under cyclosporine: a decade of experience. (1991) (27)
Relationship Between the Diagnosis, Preoperative Evaluation, and Prognosis After Orthotopic Liver Transplantation (1988) (27)
Varicella-zoster virus hepatitis and a suggested management plan for prevention of VZV infection in adult liver transplant recipients. (1995) (27)
Tacrolimus in renal transplantation. (1996) (27)
Current status of FK 506 in liver transplantation. (1991) (27)
Three years of follow-up of bone marrow-augmented organ transplant recipients: the impact on donor-specific immune modulation. (1997) (27)
Stability and sorption of FK 506 in 5% dextrose injection and 0.9% sodium chloride injection in glass, polyvinyl chloride, and polyolefin containers. (1992) (27)
Rapid en bloc technique for liver and pancreas procurement. (1997) (27)
Adenovirus-mediated gene transfer to liver grafts: an improved method to maximize infectivity. (1998) (27)
Enteric drainage of pancreas transplants revisited. (1995) (27)
Rapamycin: Friend, foe, or misunderstood? (2003) (27)
DONOR SPECIES COMPLEMENT AFTER LIVER XENOTRANSPLANTATION: THE MECHANISM OF PROTECTION FROM HYPERACUTE REJECTION1,2 (1994) (26)
Liver-Derived Dendritic Cells Induce Donor-Specific Hyporesponsiveness: Use of Sponge Implant as a Cell Transplant Model (2001) (26)
Cell banking for regulatory T cell-based therapy: strategies to overcome the impact of cryopreservation on the Treg viability and phenotype (2018) (26)
China organ donation and transplantation update: the Hangzhou Resolution. (2014) (26)
Microbiologic surveillance as part of human islet transplantation: results of the first 26 patients. (1992) (26)
Performance of Multi-Layer Feedforward Neural Networks to Predict Liver Transplantation Outcome (1996) (26)
Lymphocytes of bronchoalveolar lavages from heart-lung transplant recipients. (1985) (26)
Clonal and morphological variation in a posttransplant lymphoproliferative disorder: evolution from clonal T-cell to clonal B-cell predominance. (1998) (26)
FK 506 reverses acute graft-versus-host disease after allogeneic bone marrow transplantation in rats. (1991) (26)
Increased bile duct complications and/or chronic rejection in crossmatch positive human liver allografts. (1999) (26)
Splenic artery embolization for the treatment of refractory ascites after liver transplantation (2011) (26)
HISTOCOMPATIBILITY AND LIVER TRANSPLANT OUTCOME (1988) (26)
Reversibility of tacrolimus-induced posttransplant diabetes: an illustrative case and review of the literature. (1997) (26)
KIR and HLA Interactions Are Associated With Control of Primary CMV Infection in Solid Organ Transplant Recipients (2014) (26)
HLA antigen expression on cultured human arterial endothelial cells. (1988) (25)
Augmentation of natural chimerism with donor bone marrow in orthotopic liver recipients. (1996) (25)
C-C Chemokine Receptor Type 2–Dependent Migration of Myeloid-Derived Suppressor Cells in Protection of Islet Transplants (2017) (25)
Reasons why some children receiving tacrolimus therapy require steroids more than 5 years post liver transplantation (2001) (25)
Myeloid‐derived suppressor cells increase and inhibit donor‐reactive T cell responses to graft intestinal epithelium in intestinal transplant patients (2018) (25)
FK 506 used as rescue therapy for human liver allograft recipients. (1991) (25)
Effect of HLA mismatch in African-Americans. (1998) (25)
Infectious complications after human small bowel transplantation. (1992) (25)
Influenza A myocarditis developing in an adult liver transplant recipient despite vaccination: a case report and review of the literature. (2000) (25)
Liver transplantation in China (2007) (24)
KIDNEY TRANSPLANTATION FOR END-STAGE RENAL FAILURE IN LIVER TRANSPLANT RECIPIENTS WITH HEPATITIS C VIRAL INFECTION1 (2001) (24)
Hepatocyte-induced apoptosis of activated T cells, a mechanism of liver transplant tolerance, is related to the expression of ICAM-1 and hepatic lectin. (2001) (24)
Induction of CYP2E1 activity in liver transplant patients as measured by chlorzoxazone 6‐hydroxylation (1998) (24)
Intestinal transplantation for patients with short gut syndrome and hypercoagulable states. (2000) (24)
Clinical small bowel or small bowel plus liver transplantation under FK 506. (1991) (24)
Costimulatory molecule-deficient dendritic cell progenitors induce T cell hyporesponsiveness in vitro and prolong the survival of vascularized cardiac allografts. (1997) (24)
Infections during a randomized trial comparing cyclosporine to FK 506 immunosuppression in liver transplantation. (1992) (23)
Lack of killer immunoglobulin‐like receptor 2DS2 (KIR2DS2) and KIR2DL2 is associated with poor responses to therapy of recurrent hepatitis C virus in liver transplant recipients (2009) (23)
Pain Control, Glucose Control, and Quality of Life in Patients With Chronic Pancreatitis After Total Pancreatectomy With Islet Autotransplantation: A Preliminary Report. (2017) (23)
Vascular endothelial growth factor receptor 2 expression in non‐tumorous cirrhotic liver is higher when hepatoma is beyond milan criteria (2009) (23)
Building Clinical Classifiers Using Incomplete Observations – A Neural Network Ensemble for Hepatoma Detection in Patients with Cirrhosis (1995) (23)
Expressive dysphasia possibly related to FK506 in two liver transplant recipients. (1990) (23)
Inhibition of IL-12 signaling stat4/IFN-γ pathway by rapamycin is associated with impaired dendritc cell function (2002) (23)
Four-hour versus 24-hour intravenous infusion of FK 506 in liver transplantation. (1991) (23)
Bioartificial liver assist devices in support of patients with liver failure. (2002) (23)
High‐Resolution HLA Typing for Sensitized Patients: Advances in Medicine and Science Require Us to Challenge Existing Paradigms (2015) (23)
The politics of grafting cadaver kidneys (1996) (23)
ORTHOCLONE OKT3 in Treatment of Allografts Rejected Under Cyclosporine-Steroid Therapy. (1986) (22)
Clinical and virologic outcomes of hepatitis B and C viral coinfection after liver transplantation: Effect of viral hepatitis D (2000) (22)
Simultaneous administration of adjuvant donor bone marrow in pancreas transplant recipients. (1999) (22)
Induction of tumor immunity and cytotoxic t lymphocyte responses using dendritic cells transduced by adenoviral vectors encoding HBsAg: comparison to protein immunization (2005) (22)
COSTIMULATORY MOLECULE-DEFICmNT DENDRITIC CELL PROGENITORS (MHC CLASS 11+, CD80 dim , CD86-) PROLONG CARDIAC ALLOGRAFT SURVIVAL IN NONIMMUNOSUPPRESSED (1996) (22)
Side‐to‐side cavocavostomy with an endovascular stapler: Rescue technique for severe hepatic vein and/or inferior vena cava outflow obstruction after liver transplantation using the piggyback technique (2009) (22)
Leuconostoc bacteremia after liver transplantation: another cause of vancomycin resistant gram-positive infection. (1997) (22)
Percutaneous ultrasound-guided pancreas allograft biopsy: a single-center experience. (2005) (22)
Pediatric liver transplantation in 808 consecutive children: 20-years experience from a single center. (2002) (22)
Influence of donor condition on postoperative graft survival and function in human liver transplantation. (2000) (22)
Phenytoin Decreases the Blood Concentrations of Sirolimus in a Liver Transplant Recipient: A Case Report (2003) (22)
Studies of the hepatotrophic qualities of FK 506 and CyA. (1990) (21)
Tacrolimus without antilymphocyte induction therapy prevents pancreas loss from rejection in 123 consecutive patients. (1998) (21)
Dendritic cell replacement in long-surviving liver and cardiac xenografts. (1993) (21)
ALLOREACTIVE T LYMPHOCYTES CULTURED FROM LIVER TRANSPLANT BIOPSIES: ASSOCIATIONS OF HLA SPECIFICITY WITH CLINICOPATHOLOGICAL FINDINGS. (1988) (21)
Growth Factor-Induced Mobilization of Dendritic Cells in Kidney and Liver of Rhesus Macaques: Implications for Transplantation (2007) (21)
Intestinal transplantation in humans under FK 506. (1993) (21)
Acute hemolytic anemia in liver and bone marrow transplant patients under FK 506 therapy. (1991) (21)
Ischemic preconditioning: Application in clinical liver transplantation (2001) (21)
Clinical Significance of Elevated α-Fetoprotein in Adults and Children (2004) (21)
ISOLATION OF THE REGULATORY REGIONS AND GENOMIC ORGANIZATION OF THE PORCINE &agr;1,3-GALACTOSYLTRANSFERASE GENE1 (2000) (20)
Experimental animal model of graft-versus-host disease (GVHD) after small-bowel transplantation: characteristics of the model and application to developing treatment strategies. (1997) (20)
The two-way paradigm of transplantation immunology. (1996) (20)
Intravenous, oral pharmacokinetics, and oral dosing of FK 506 in small bowel transplant patients. (1992) (20)
Hamster coagulation and serum proteins in rat recipients of hamster xenografts. (1993) (20)
Role of nuclear medicine in liver transplantation. (1995) (20)
FK 506 in solid organ transplantation. (1994) (20)
Radiologic-histological correlation of hepatocellular carcinoma treated via pre-liver transplant locoregional therapies. (2013) (20)
Early detection of de novo hepatitis C infection in patients after liver transplantation by reverse transcriptase polymerase chain reaction. (1993) (20)
Excision and immediate revascularization for hepatic artery pseudoaneurysm following liver transplantation (1999) (20)
Preliminary experience with FK 506 in thoracic transplantation (1991) (20)
Clinical intestinal transplantation. (1996) (20)
Clinical intestinal transplantation: focus on complications. (1992) (20)
Psychiatric morbidity in liver transplant patients. (1991) (20)
Pancreas transplantation with enteric drainage under tacrolimus induction therapy. (1997) (19)
Duct-to-duct biliary reconstruction in patients with primary sclerosing cholangitis undergoing liver transplantation. (2011) (19)
Living donor liver transplantation: ethics and safety. (2003) (19)
Induction of Donor-Specific Transplantation Tolerance to Skin and Cardiac Allografts Using Mixed Chimerism in (A + B → A) in Rats (1993) (19)
Program death-1 immune checkpoint and tumor microenvironment in malignant liver tumors. (2017) (19)
Loco-regional therapy in patients with Milan Criteria-compliant hepatocellular carcinoma and short waitlist time to transplant: an outcome analysis. (2012) (19)
Apoptosis of graft-infiltrating cytotoxic T cells: a mechanism underlying "split tolerance" in mouse liver transplantation. (1997) (19)
Augmentation of chimerism with perioperative donor bone marrow infusion in organ transplant recipients: a 44 month follow-up. (1997) (19)
Bronchiolitis obliterans organizing pneumonia in a BMT patient receiving FK506. (1993) (19)
Limitations of current liver transplant immunosuppressive regimens: renal considerations. (2017) (19)
Humoral and cellular immunopathology of hepatic and cardiac hamster-into-rat xenograft rejection. Marked stimulation of IgM++bright/IgD+dull splenic B cells. (1993) (19)
Upper-abdominal exenteration in transplantation for extensive malignancies of the upper abdomen--an update. (1991) (19)
A new class of cyclosporin analogues for the treatment of asthma (2003) (19)
Functional differentiation of human cytotoxic T lymphocytes in the presence of FK 506 and CyA. (1990) (19)
Presence of retinal pericyte-reactive autoantibodies in diabetic retinopathy patients (2016) (19)
Interaction between tacrolimus and antiretroviral agents in human immunodeficiency virus-positive liver and kidney transplantation patients. (2002) (19)
Small bowel transplantation: current progress and clinical application. (1996) (19)
Comparison of Tacrolimus Absorption in Transplant Patients Receiving Continuous versus Interrupted Enteral Nutritional Feeding (1998) (19)
An attempt to reverse diabetes by delayed islet cell transplantation in humans. (1997) (19)
A cost comparison of liver transplantation with FK 506 or CyA as the primary immunosuppressive agent. (1990) (18)
Reversal of Graft-Versus-Host Disease with Infusion of Autologous Bone Marrow (1994) (18)
Analysis of T lymphocytes infiltrating human hepatic allografts. (1987) (18)
Infections with FK 506 immunosuppression: preliminary results with primary therapy. (1990) (18)
Four-color flow cytometric analysis of peripheral blood donor cell chimerism. (2003) (18)
OKT3 in the reversal of acute hepatic allograft rejection. (1987) (18)
Intestinal transplantation at the University of Pittsburgh. (1994) (18)
What is the best staging system for hepatocellular carcinoma in the setting of liver transplantation? (2011) (18)
Presensitization by skin grafting from major histocompatibility complex class I or major histocompatibility complex class II deficient mice identifies class I antigens as inducers of allosensitization. (1995) (18)
Prognostic role of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma undergoing liver transplantation (2015) (18)
The liver allograft, chronic (ductopenic) rejection, and microchimerism: what can they teach us? (1995) (18)
Influence of FK 506 (tacrolimus) on circulating CD4+ T cells expressing CD25 and CD45RA antigens in 19 patients with chronic progressive multiple sclerosis participating in an open label drug safety trial. (1994) (18)
Preoperative assessment of risk in liver transplantation: a multivariate analysis in 2376 cases of the UW era. (1997) (18)
CD6 Receptor Regulates Intestinal Ischemia/Reperfusion-induced Injury by Modulating Natural IgM-producing B1a Cell Self-renewal* (2016) (18)
Liver Transplantation for Colorectal and Neuroendocrine Liver Metastases and Hepatoblastoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference. (2020) (18)
Hepatic Stellate Cells Directly Inhibit B Cells via Programmed Death–Ligand 1 (2016) (18)
Association Between Renal Dysfunction and Major Adverse Cardiac Events After Liver Transplantation: Evidence from an International Randomized Trial of Everolimus-Based Immunosuppression (2018) (17)
Long-term survival of heart and liver xenografts with splenectomy and FK 506. (1993) (17)
Autologous lymphokine-activated killer cell therapy of lymphoproliferative disorders arising in organ transplant recipients. (1997) (17)
Livers transplanted from donors after cardiac death occurring in the ICU or the operating room have excellent outcomes. (2005) (17)
Adult heart transplantation under tacrolimus (FK506) immunosuppression: histopathologic observations and comparison to a cyclosporine-based regimen with lympholytic (ATG) induction. (1997) (17)
Marked mitigation of transplant vascular sclerosis in FasLgld (CD95L) mutant recipients. The role of alloantibodies in the development of chronic rejection. (1999) (17)
Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression. (1993) (17)
Allogeneic hematolymphoid microchimerism and prevention of autoimmune disease in the rat. A relationship between allo- and autoimmunity. (1996) (17)
Isolated right hepatic vein obstruction after piggyback liver transplantation (2006) (17)
Surgical complications in 275 HIV-infected liver and/or kidney transplantation recipients. (2012) (17)
FK 506 dosage in human organ transplantation. (1990) (17)
Renal function after conversion from cyclosporine to FK 506 in liver transplant patients. (1991) (17)
Effect of FK 506 on human pancreatic islets following renal subcapsular transplantation in diabetic nude mice. (1992) (16)
Inhibition of IL-12 signaling Stat4/IFN-gamma pathway by rapamycin is associated with impaired dendritic [correction of dendritc] cell function. (2002) (16)
Porcine cell microchimerism but lack of productive porcine endogenous retrovirus (PERV) infection in naive and humanized SCID-beige mice treated with porcine peripheral blood mononuclear cells. (2004) (16)
Effect of Age and Postoperative Time on Cytochrome P450 Enzyme Activity Following Liver Transplantation (2005) (16)
Hepatitis G virus coinfection in hepatitis C virus-infected liver transplant recipients. (1997) (16)
Treatment of isolated pancreatic islets to reverse pancreatectomy-induced and insulin-dependent type I diabetes in humans: a 6-year experience. (1997) (16)
Sequential infiltration of class I and class II specific alloreactive T cells in human cardiac allografts. (1987) (16)
Abdominal organ retrieval and transplantation bench surgery (2013) (16)
Humoral rejection associated with antidonor lymphocytotoxic antibodies following liver transplantation. (1993) (16)
Tolerance-Inducing Strategies in Islet Transplantation (2012) (16)
CMV infection in liver transplantation under cyclosporine or FK 506 immunosuppression. (1991) (16)
Recipient pretreatment with mammalian IL-10 prolongs mouse cardiac allograft survival by inhibition of anti-donor T cell responses. (1999) (16)
Enteric-drained pancreas transplants monitored by fine-needle aspiration biopsy. (1997) (15)
Excision and immediate revascularization for hepatic artery pseudoaneurysm following liver transplantation. (1998) (15)
Prevention of T-cell activation by rhCTLA4-Ig and anti-CD40L monoclonal antibody results in indefinite islet allograft survival. (1999) (15)
Isolation and primary cultures of human intrahepatic bile ductular epithelium (1988) (15)
In vivo expansion of two distinct dendritic cells in mouse livers and its impact on liver immune regulation (2006) (15)
The effect of Guidelines in surgical decision making: The paradigm of hepatocellular carcinoma. (2016) (15)
Oncologic results of laparoscopic liver resection for malignant liver tumors (2016) (15)
Tacrolimus for rescue of refractory renal allograft rejection. (1998) (15)
Invasive Aspergillosis In Liver Transplant Recipients: Comparison Of Outcome With Amphotericin B Lipid-complex And Conventional Amphotericin B Therapy (1999) (15)
Composition of human islet cell preparations for transplantation (2004) (14)
Transplant Tourism and Unregulated Black‐Market Trafficking of Organs (2009) (14)
Changes in quality of life following conversion from CyA to FK 506 in orthotopic liver transplant patients. (1991) (14)
Synergistic effect of cold and warm ischemia time on postoperative graft outcome in human liver transplantation. (2004) (14)
Liver transplantation at the University of Pittsburgh, 1984 to 1990. (1991) (14)
The effect of bile duct ligation and bile diversion on FK506 pharmacokinetics in dogs. (1992) (14)
Daily serum interleukin-6 monitoring in multiple organ transplantation with or without liver allografts. (1996) (14)
Clinical significance of elevated alpha-fetoprotein in adults and children. (2001) (14)
Toward tolerance: lessons learned from liver transplantation. (1999) (14)
Results of simultaneous and sequential pediatric liver and kidney transplantation. (1998) (14)
Human islet allotransplantation under FK 506. (1991) (14)
Comparison of the small intestine after multivisceral transplantation with the small intestines transplanted with portal or caval drainage. (1992) (13)
Use of prostaglandin E1 in crossmatch-negative liver transplant recipients treated with FK 506. (1993) (13)
Kaposi's sarcoma in liver transplant recipients on FK506. (1998) (13)
Augmentation of Type-1 Polarizing Ability of Monocyte-Derived Dendritic Cells from Chronically Immunosuppressed Organ-Transplant Recipients (2005) (13)
The role of liver‐derived regulatory dendritic cells in prevention of type 1 diabetes (2007) (13)
Transjugular intrahepatic portosystemic shunt in liver transplant recipients: indications, feasibility, and outcomes (2015) (13)
Cytokine profile in graft-versus-host disease after small bowel transplantation. (1996) (13)
Does transjugular intrahepatic portosystemic shunt (TIPS) resolve thrombocytopenia associated with cirrhosis (1999) (13)
Intrahepatic human islet transplantation at the University of Pittsburgh: results in 25 consecutive cases. (1992) (13)
Comparative in vitro studies on the immunosuppressive effects of purine and pyrimidine synthesis inhibitors. (1993) (13)
Hepatocytes and liver nonparenchymal cells induce apoptosis in activated T cells. (1999) (13)
Establishment of Primary Cultures of Human Biliary Epithelium and Induction of Class II Major Histocompatibility Complex Antigens by Interferon Gamma. (1988) (13)
Clinical intestinal transplantation in 1998: Pittsburgh experience. (1999) (12)
Perioperative and oncologic outcomes of minimally invasive liver resection for colorectal metastases: A case-control study of 130 patients. (2016) (12)
Effect of OKT3 on survival and rate of retransplantation. (1987) (12)
Spindle cell tuor of the portal vein (1995) (12)
Nutritional management of intestinal allograft recipients. (1998) (12)
Adjuvant bone marrow infusion in clinical organ transplant recipients. (1998) (12)
Treatment of Cogan's syndrome with FK 506: a case report. (1991) (12)
PATTERNS OF INFLAMMATORY VASCULAR ENDOTHELIAL CHANGES IN MURINE LIVER GRAFTS (1995) (12)
OCCULT NONHEMATOPOIETIC MALIGNANCIES PRESENT AT AUTOPSY IN SOLID ORGAN TRANSPLANT PATIENTS WHO DIED WITHIN 100 DAYS (2001) (12)
Assessment of simple indices based on a single fasting blood sample as a tool to estimate beta‐cell function after total pancreatectomy with islet autotransplantation – a prospective study (2018) (12)
Enhancing kidney function with thrombolytic therapy following donation after cardiac death: a multicenter quasi‐blinded prospective randomized trial (2015) (12)
Enhancement of dendritic cell tolerogenicity by genetic modification using adenoviral vectors encoding cDNA for TGFβ1 (1999) (12)
Prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil: complete report on 350 primary adult liver transplantations. (2001) (12)
Complement mediated hepatocytes injury in a model of autoantibody induced hepatitis. (2011) (12)
Use of non-heart-beating donors. (2000) (12)
Metabolic effects of FK 506 in patients with severe psoriasis: short-term follow-up of seven cases. (1991) (12)
Capillary blood versus arterial or venous blood for tacrolimus monitoring in liver transplantation. (1995) (12)
Fine-needle aspiration biopsy in pancreatic transplantation. (1995) (12)
Reducing the length of stay after kidney transplantation--the intensive outpatient unit. (1998) (12)
Pharmacokinetics of cyclosporine and nephrotoxicity in orthotopic liver transplant patients rescued with FK 506. (1991) (12)
COVID‐19 in hospitalized liver transplant recipients: An early systematic review and meta‐analysis (2021) (12)
Bronchoalveolar macrophage-lymphocyte reactivity in heart-lung transplant recipients. (1987) (12)
Translocation of bacteria from the gastrointestinal tract: protection afforded by lisofylline. (1999) (12)
Safety and Efficacy of a New Bipolar Energy Device for Parenchymal Dissection in Laparoscopic Liver Resection (2016) (12)
Almost total absence of chronic rejection in primary pediatric liver transplantation under tacrolimus. (2002) (12)
Second-set rejection of mouse liver allografts is dependent on radiation-sensitive nonparenchymal cells of graft bone marrow origin. (1996) (12)
Efficacy and Safety of Everolimus With Reduced Tacrolimus in Liver Transplant Recipients: 24-month Results From the Pooled Analysis of 2 Randomized Controlled Trials (2020) (11)
Use of the D-xylose absorption test in monitoring intestinal allografts. (1994) (11)
Oral glucose tolerance test in liver recipients treated with FK 506. (1990) (11)
Prolonged survival of islet allografts following combined therapy with tacrolimus and leflunomide. (1999) (11)
Stromal cell-based immunotherapy in transplantation. (2011) (11)
Comparative evaluation of simple indices using a single fasting blood sample to estimate beta cell function after islet transplantation (2018) (11)
Mouse liver transplantation tolerance: the role of hepatocytes and nonparenchymal cells. (1995) (11)
Tolerance and chimerism in liver transplantation. (1997) (11)
Cytokine messenger RNA profiles in hamster-to-rat liver xenografts. (1993) (11)
Combined blockade of CD28/B7 and CD40/CD40L costimulatory pathways prevents the onset of chronic rejection. (1998) (11)
Influence of HLA and CREG matching in African-American primary cadaver kidney recipients: UNOS 1991-1995. (1997) (11)
Donor IFNL4 Genotype Is Associated with Early Post-Transplant Fibrosis in Recipients with Hepatitis C (2016) (11)
Effect of donor age and sex on the outcome of liver transplantation (1995) (11)
Human islet allotransplantation in 18 diabetic patients. (1992) (11)
Natural history of Epstein-Barr viral load in peripheral blood of pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disorder. (1998) (11)
The Prognostic Value of Kidney Transplant Center Report Cards (2013) (11)
The demise of islet allotransplantation in the United States: A call for an urgent regulatory update (2021) (11)
Early infections in kidney transplant recipients under FK 506. (1991) (11)
The long-term efficacy of multivisceral transplantation. (2000) (11)
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. (1987) (11)
BETA‐2 score is an early predictor of graft decline and loss of insulin independence after pancreatic islet allotransplantation (2019) (11)
Some morphological, growth, and genomic properties of human cells chronically infected with porcine endogenous retrovirus (PERV). (2003) (11)
Impact of De Novo and Preexisting Inflammatory Bowel Disease on the Outcome of Orthotopic Liver Transplantation (2016) (11)
Attenuation of aortic graft arteriosclerosis by systemic administration of Allotrap peptide RDP58 (2002) (10)
Pancreatitis after liver transplantation in children: a single-center experience (2003) (10)
Transjugular intrahepatic portosystemic shunt for liver transplantation. (2002) (10)
Pyruvate inhibits the chronic damage which ensues after ischemia/reperfusion injury of kidneys. (1999) (10)
Primary cultures of human intrahepatic (biliary) epithelial cells. (1988) (10)
Reversal of protein‐losing enteropathy after liver transplantation in a child with idiopathic familial neonatal hepatitis (2009) (10)
55 MYCOPHENOLATE MOFETIL HAS NO EFFECT ON TACROLIMUS PHARMACOKINETICS IN LIVER TRANSPLANT PATIENTS (1997) (10)
The pitfall of the cystic duct biliary anastomosis in right lobe living donor liver transplantation (2004) (10)
FK 506 reverses acute graft-versus-host disease following allogeneic bone marrow transplantation in rats (1991) (10)
RECURRENCE OF PRIMARY SCLEROSING CHOLANGITIS (PSC) AFTER HEPATIC TRANSPLANTATION: SINGLE CENTER EXPERIENCE WITH 380 GRAFTS. (1999) (10)
Origin of lymph node-derived lymphocytes in human hepatic allografts. (1989) (10)
Detection of intrahepatic human islets following combined liver-islet allotransplantation. (1992) (10)
Induced pluripotent stem cells-derived myeloid-derived suppressor cells regulate the CD8+ T cell response. (2018) (10)
Effects of in vivo treatment with FK506 on natural killer cells in rats. (1991) (10)
Kidney transplantation with bone marrow augmentation: five-year outcomes. (2001) (10)
Tacrolimus enhances the immunosuppressive effect of cyclophosphamide but not that of leflunomide or mycophenolate mofetil in a model of discordant liver xenotransplantation. (1998) (10)
Liver transplantation at Cleveland Clinic. (2010) (10)
The Demise of Islet Allotransplantation in the US: A Call for an Urgent Regulatory Update The "ISLETS FOR US" Collaborative. (2020) (10)
A new xenogeneic radiation chimera (hamster-to-rat). (1994) (10)
Revascularization of the gastroduodenal artery in a pancreas allograft from a donor with a replaced right hepatic artery. (2005) (10)
Cadaveric liver donors; what are the limits? (1996) (10)
Monitoring the patient off immunosuppression (2001) (10)
Acute hemodynamic effects of FK 506 during and after orthotopic liver transplantation. (1990) (10)
Alcoholic liver disease and transplantation. (2003) (9)
Transduction of dendritic cells with adenoviral vectors encoding CTLA4- Ig markedly reduces their allostimulatory activity (1999) (9)
Cross-tolerance of recipient-derived transforming growth factor-beta dendritic cells. (2007) (9)
Patient Participation in Research Among Solid Organ Transplant Recipients in the United States (2011) (9)
Application of recipient-derived dendritic cells to induce donor-specific T-cell hyporesponsiveness. (2004) (9)
Serial monitoring of immunologic function and phenotype of lymphocytes in the blood of transplanted patients randomized to cyclosporine or FK 506. (1991) (9)
Long-term results of pancreas transplantation under tacrolius immunosuppression. (1999) (9)
Changes in biliary (high-molecular-mass) and liver isoforms of alkaline phosphatase after baboon-to-human liver transplantation. (1994) (9)
Liver transplantation in patients with incidental hepatocellular carcinoma/cholangiocarcinoma and intrahepatic cholangiocarcinoma: a single-center experience. (2017) (9)
Effect of FK 506 on FK-binding protein and transforming growth factor beta gene expression. (1991) (9)
Endothelin-1 receptor blockade and its effect on chronic rejection. (1999) (9)
Recipient But Not Donor Adiponectin Polymorphisms Are Associated With Early Posttransplant Hepatic Steatosis in Patients Transplanted for Non-Nonalcoholic Fatty Liver Disease Indications. (2018) (9)
Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation (2016) (8)
Experiences relating to management of biliary tract complications following liver transplantation in 96 cases. (2002) (8)
Kaposi's sarcoma in two primary liver allograft recipients occurring under FK506 immunosuppression. (1993) (8)
Factors affecting surgical margin recurrence after hepatectomy for colorectal liver metastases. (2016) (8)
History of Liver and Multivisceral Transplantation (2005) (8)
The Rationale for FK 506 in Inflammatory Bowel Disease (1993) (8)
Allospecificity of liver allograft-derived lymphocytes and correlation with clinicopathologic findings. (1988) (8)
Alopecia as a consequence of tacrolimus therapy. (1998) (8)
Systemic administration of CTLA4-Ig or anti-CD40 ligand antibody inhibits second-set rejection of mouse liver allografts. (1999) (8)
A prospective, randomized trial of tacrolimus/prednisone vs tacrolimus/prednisone/mycophenolate mofetil in renal transplantation: 1-year actuarial follow-up. (1999) (8)
Intestinal transplantation with or without other abdominal organs: nutritional and dietary management of 50 patients. (1994) (8)
Low-dose of FK 506 and associated blood levels in allotransplantation of rat liver, heart, and skin. (1992) (8)
Donor-specific bone marrow infusion after orthotopic liver transplantation. Rolles K, Burroughs AK, Davidson BR, Karatapanis S, Prentice HG, Hamon MD. Lancet 1994; 263-265 (1995) (8)
Retransplantation of liver: a comparison of FK 506- and cyclosporine-treated patients. (1991) (8)
Evidence that canine pancreatic islets promote the survival of human hepatocytes in nude mice. (1991) (8)
Donor pretreatment with FLT-3 ligand augments anti-donor CTL, NK and LAK cell activities within liver allografts and alters the pattern of intragraft apoptotic activity (1998) (8)
New technique in hepatic parenchymal transection for living related liver donor and liver neoplasms. (2004) (8)
Tacrolimus (FK506) and the pharmaceutical/academic/regulatory gauntlet. (1998) (7)
Valuation of transmission of porcine endogenous retrovirus into patients subjected to hemoperfusion using an extracorporeal bioartificial liver support system. (2001) (7)
CAMPATH PRECONDITIONING AND TACROLIMUS MONOTHERAPY WITH SUBSEQUENT WEANING IN RENAL TRANSPLANT RECIPIENTS (2004) (7)
The role of the A2a receptor agonist, regadenoson, in modulating hepatic artery flow in the porcine small-for-size liver graft. (2012) (7)
Viable strategies to facilitate liver transplantation for human immunodeficiency virus coinfection (2009) (7)
Total pancreatectomy with islet autotransplantation in diabetic and pre-diabetic patients with intractable chronic pancreatitis (2020) (7)
Everolimus With Reduced Tacrolimus in Liver Transplantation (2013) (7)
Prolonged prevention of acute graft-versus-host disease after allogeneic bone marrow transplantation by donor pretreatment using FK 506. (1991) (7)
[Experience of orthotopic liver transplantation from non-heart-beating donors at the University of Pittsburgh Medical Center]. (1999) (7)
Perioperative donor bone marrow infusion in recipients of organ allografts. (1997) (7)
The effect of cyclosporine, rapamycin and FK 506 the survival following allogeneic bone marrow transplantation. (1991) (7)
Original articleAcute liver failure: Clinical features, outcomeanalysis, and applicability of prognostic criteria (2000) (7)
The dichotomous functions of passenger leukocytes in solid-organ transplantation. (1995) (7)
Elevated catecholamines and hepatic artery vasospasm in porcine small-for-size liver graft. (2012) (7)
Cardiac changes at autopsy in adult liver transplant recipients under tacrolimus. (1997) (7)
The lymphocytotoxic crossmatch in liver transplantation: a clinicopathologic analysis. (1991) (7)
Ischemia/reperfusion injury induces chronic changes in the small bowel. (2000) (7)
Renal function with everolimus and reduced tacrolimus in de novo liver transplant recipients: 12 month results of the H2304 trial. O-17 (2012) (7)
Ontogeny of Clonal Dominance (1979) (7)
Early Infectious Complications After Total Pancreatectomy with Islet Autotransplantation: a Single Center Experience (2019) (7)
Long-term nutritional monitoring after clinical intestinal transplantation. (1998) (7)
Enhancement of dendritic cell tolerogenicity by genetic modification using adenoviral vectors encoding cDNA for TGF beta 1. (1998) (7)
Transduction of dendritic cells with adenoviral vectors encoding CTLA4-Ig markedly reduces their allostimulatory activity. (1998) (7)
The combined use of sublethal irradiation and costimulatory blockade to generate mixed bone marrow chimeras. (1999) (7)
Vascular endothelial growth factor receptor 2 (VEGFr2) expression and recurrence of hepatocellular carcinoma following liver transplantation: The Cleveland Clinic experience (2008) (7)
Mechanistic insights into achievement of cardiac allograft long-term survival by treatment with immature dendritic cells and sub-dose sirolimus. (2006) (7)
Sterility of bile in multiple-organ donors. (1990) (7)
Minimally invasive resection of posterosuperior liver tumors in the supine position using intra-abdominal trocars (2019) (6)
Effect of t-tube clamping on the pharmacokinetics of mycophenolic acid in liver transplant patients on oral therapy of mycophenolate mofetil. (1999) (6)
Use of autologous dendritic cells loaded with apoptotic LCL for ex vivo generation of specific CTL from the PBMC of EBV(-) individuals. (2001) (6)
Evolution of a laparoscopic liver resection program: an analysis of 203 cases (2017) (6)
Evidence for engraftment of human bone marrow cells in non-lethally irradiated baboons. (1997) (6)
Incidence Of End-Stage Renal Failure Amongst Long-term Survival Of Primary Liver Transplant Recipients Under Tacrolimus: Adults and Children (1998) (6)
Tacrolimus rescue therapy for renal transplant rejection. (1996) (6)
Role of UW solution and sodium nitroprusside in reperfusion of liver xenografts from guinea‐pig to rat (1999) (6)
Treatment with CTLA4-Ig inhibits rejection of liver allografts from FIt3-ligand-treated donors. (1999) (6)
A pilot trial of tacrolimus, sirolimus, and steroids in renal transplant recipients. (2002) (6)
Transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension (1994) (6)
Comparison of the small intestines after multivisceral transplantation and the small intestine transplanted with portal versus caval drainage (1992) (6)
Combined liver and kidney transplantation with particular reference to positive cytotoxic crossmatches (1989) (6)
The current status of hepatic transplantation at the University of Pittsburgh. (1995) (6)
The effect of splenectomy on cardiac and liver xenografts in the nude rat. (1994) (6)
Human islet allograft follow-up: long-term islet function and over 3 years of insulin independence. (1994) (6)
Late severe rejection of intestinal allografts: risks and survival outcome. (2001) (6)
State of immunosuppressive agents in organ transplantation. (1992) (6)
OUTCOME AFTER STEROID WITHDRAWAL IN ADULT RENAL TRANSPLANT PATIENTS RECEIVING TACROLIMUS‐BASED IMMUNOSUPPRESSION.: Abstract# 425 Poster Board #‐Session: P65‐II (2000) (6)
Short exposure to hepatocyte growth factor stimulates adult human pancreatic beta-cell proliferation. (1995) (6)
Liver graft induced donor specific unresponsiveness without class I and/or class II antigen differences. (1993) (6)
Prophylactic use of OKT3 in liver transplantation (1991) (6)
Immunosuppressive Therapy in Solid Organ Transplantation (2002) (6)
Outcome of tacrolimus conversion therapy for renal allograft rejection: 5-year follow-up. (1999) (6)
Liver transplantation for growing teratoma syndrome: Report of a case (2003) (6)
812 Applicability of MELD scoring system to predict prognosis in patients with acute liver failure (2003) (6)
Pretreatment of recipients (nude rat) with donor antigens leads to prolonged survival of hamster heart xenografts. (1996) (6)
Eating difficulties in the pediatric small bowel recipient: the role of the nutritional management team. (1994) (6)
Posttransplant diabetes in pediatric recipients on tacrolimus. (1999) (6)
Liver transplantation of American veterans under FK 506 immunosuppression: a preliminary report. (1991) (6)
Histologic monitoring of human small bowel allografts with clinical correlation. (1992) (6)
Preservation injury and acute rejection of rat intestinal grafts: Protection afforded by pyruvate (1999) (6)
The rationale for equitable liver allocation. (1996) (6)
Tacrolimus pretreatment attenuates preexisting xenospecific immunity and abrogates hyperacute rejection in a presensitized hamster to rat liver transplant model. (1996) (6)
Human islet transplantation: results of the first 37 patients. (1995) (6)
Everolimus Impact On Hepatocellular Carcinoma Recurrence After Liver Transplantation - 12, 24, and 36 Months Data From 719 Liver Transplant Recipients.: Abstract# A376 (2014) (5)
Uterus Transplantation: Medical Considerations (2016) (5)
Cruveilhier‐Baumgarten disease in a patient with turner syndrome: Case report of a rare indication for liver transplantation (2008) (5)
Liver Transplantation in HIV-Seropositive Individuals (2006) (5)
Short-term survival with combined heart-kidney or combined heart-liver transplantation with allografts from a single donor. (2001) (5)
Pretransplant xenogeneic blood transfusion combined with FK 506 prolongs hamster-to-rat liver xenograft survival. (1994) (5)
Simultaneous heart, liver and kidney transplantation: A viable option for heart failure patients with multiorgan failure. (2019) (5)
Renal retransplantation in elderly recipients under tacrolimus-based immunosuppression. (2000) (5)
Effect of recipient race on waiting time for renal transplantation at the University of Pittsburgh. (1993) (5)
Interaction between FK 506 and cyclosporine in dogs. (1991) (5)
Diagnosis and management of rare inferior vena cava leiomyosarcoma guided by a novel minimally invasive vascular biopsy technique (2018) (5)
Isolated intestinal versus composite visceral allografts: causes of graft failure. (2000) (5)
Validation of a New North American Islet Donor Score for Donor Pancreas Selection and Successful Islet Isolation in a Medium-Volume Islet Transplant Center (2018) (5)
A Comparison of the Initial Cost Associated With Resection Versus Laparoscopic Radiofrequency Ablation of Small Solitary Colorectal Liver Metastasis (2018) (5)
Venous-right atrial bypass for superior vena cava thrombosis during orthotopic liver transplantation. (1997) (5)
A randomized trial of early administration of inhaled cyclosporine in lung transplant recipients (2004) (5)
Three dimensional surface mapping and simulation of FK506 dose-level relationships (1993) (5)
Association Between Liver Transplant Center Performance Evaluations and Transplant Volume: Potential Unintended Consequence of Quality Oversight.: Abstract# 2257 (2014) (5)
Steroid withdrawal under tacrolimus for primary biliary cirrhosis, primary sclerosing cholangitis and autoimmune hepatitis after liver transplantation and long-term survival. (2002) (5)
Interaction between tracolimus and erythromycin (Letter) (1994) (5)
Daily serum inflammatory cytokine (tumor necrosis factor-alpha, interleukin-6) monitoring in liver transplantation focusing on allograft rejection: a five-case report. (1996) (5)
Phenotype and allostimulatory function of dendritic cells treated with antisense oligodeoxyribonucleotides targeting CD80 or CD86 mRNA. (2001) (5)
External Validation of the Newly Developed BETA-2 Scoring System for Pancreatic Islet Graft Function Assessment. (2017) (5)
Hamster‐to‐rat bone marrow xenotransplantation and humoral graft vs. host disease (2001) (5)
Concomitant infusion of unmodified donor bone marrow into unconditioned recipients of intestinal allografts. (1996) (5)
Transplant innovation and ethical challenges: what have we learned? A collection of perspectives and panel discussion. (2008) (5)
Oxygen consumption predicts outcome in porcine partial liver grafts. (2014) (5)
Role of MHC class I and CD8(+) T cells in the pathogenesis of chronic rejection. (2001) (5)
A novel subset of dendritic cells propagated from the liver promotes differentiation of T regulatory cells and enhances allograft survival. (2001) (5)
Hepatis B virus (HBV) re-infection following liver transplantation: Theory and practice (1995) (5)
Spur cell anemia as a cause of unconjugated hyperbilirubinemia after liver transplantation and its resolution after retransplantation (2011) (5)
Propagation of cells expressing donor phenotype (MHC class I, II and Y-chromosome) from the bone marrow of murine liver allograft recipients in response to GM-CSF in vitro. (1995) (4)
Five-year experience with tacrolimus rescue for renal allograft rejection. (1997) (4)
Su1038 Liver Transplantation for Nonalcoholic Steatohepatitis (NASH) in Children and Young Adults: The True Burden of Pediatric Nonalcoholic Fatty Liver Disease (2015) (4)
Long-term follow-up of tacrolimus rescue therapy for renal allograft rejection. (1997) (4)
Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms. (1999) (4)
Donor-specific transfusion in the nude rat prolongs survival of subsequently transplanted hamster cardiac xenografts. (1997) (4)
Prolonged survival of hearts obtained from chimeric donors in a mouse to rat xenotransplant model. (1996) (4)
Post-transplant lymphoproliferative disorders (PTLD) in liver transplantation (LTX): A twenty year experience (2002) (4)
Hepatopulmonary syndrome: A reversible disease by orthotopic liver transplantation (1995) (4)
In situ Liver Splitting (2013) (4)
INDOLEAMINE 2, 3 ‐ DIOXYGENASE BLOCKADE PREVENTS SPONTANEOUS LIVER ALLOGRAFT TOLEROGENICITY IN THE MOUSE.: Abstract# 714 (2000) (4)
FcγRllc 13Q/STP polymorphism influences the antibody-dependent cytotoxicity levels triggered by natural killer cells against pig aortic endothelial cells (2001) (4)
Glucose balance of porcine liver allograft is an important predictor of outcome. (2011) (4)
Outcomes in 139 cases of biliary tract reconstructions from a transplant surgery center. (2003) (4)
Acute Renal Failure Requiring Dialysis in Liver Transplant Recipients under Tacrolimus, Prednisone vs Tacrolimus, Prednisone and Cellcept (1999) (4)
Hamster-to-rat liver xenografts protect extrahepatic organs from rejection. (1993) (4)
Mechanisms of protection from humoral rejection by a xenografted liver. (1995) (4)
FK 506 prolongs survival of liver but not heart mouse-to-rat vascularized xenografts. (1994) (4)
Donor bone marrow infusion in liver recipients: effect on the occurrence of acute cellular rejection. (2001) (4)
Adenosine Increases Hepatic Artery Flow in Liver Transplant Recipients: A Pilot Study. (2016) (4)
Suppression of alloreactive T-cell activation by murine liver F4/80+ accessory cells and kinetics of intrahepatic F4/80+ cells following liver transplantation. (1995) (4)
Defining the alcoholic liver transplant population: Implications for future research (2001) (4)
Pathologic analysis of recurrent posttransplant lymphoproliferative disorders. (1995) (4)
HEPATOTROPHIC EFFECTS OF FK 506 IN DOGS ! (2010) (4)
A new technique for hepatic parenchymal transection using an articulating bipolar 5 cm radiofrequency device: results from the first 100 procedures. (2018) (4)
Evaluation of the influence of FK 506, rapamycin, and cyclosporine on processing and presentation of particulate antigen by macrophages: assessment of a drug "carry-over" effect. (1991) (4)
Early clinical and histologic viability of human liver-small intestinal allografts after implantation. (1994) (4)
Autologous lymphokine-activated killer (LAK) cell therapy of EBV+ and EBV- lymphoproliferative disorders arising in organ transplant recipients (1997) (4)
Persistence of donor-reactive T cells after liver transplantation-induced tolerance in mice. (1993) (3)
mTOR inhibition in liver transplantation: how to dose for effective/safe CNI reduction? (2012) (3)
Administration of antisense oligodeoxyribonucleotides against mRNA of CD80 or CD86 prolongs survival of cardiac allografts by inhibition of CTL activity. (2001) (3)
The successful use of telaprevir to treat hepatitis C recurrence after liver transplantation in an HIV co-infected patient. (2014) (3)
SYSTEMIC ADMINISTRATION OF CTLA4-Ig OR ANTI-CD40 LIGAND ANTIBODY INHIBITS SECOND-SET REJECTION OF MOUSE LIVER ALLOGRAFTS (1998) (3)
DIFFERENTIAL EFFECTS OF EXOGENOUS INTERLEUKIN-10 ON CARDIAC ALLOGRAFT SURVIVAL 1,2 (1999) (3)
INCIDENCE OF POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN ADULTS AND CHILDREN: CONSECUTIVE 1000 PRIMARY LIVER TRANSPLANT RECIPIENTS UNDER TACROLIMUS. (1999) (3)
Primary Liver Transplantation in children under Tacrolimus:3 to 8 years actual follow-up (1998) (3)
Correction of congenital hyperbilirubinemia in homozygous Gunn rats by xenotransplantation of hamster livers (1997) (3)
Rapid Temporary Portosystemic Bypass (2002) (3)
The role of liver stromal cells in dendritic cells development in mice. (2010) (3)
Efficacy of CMV antigeemia directed preemptive therapy with ganciclovir at one year in liver transplant recipients pretreated with thymoglobulin or alemtuzumab (2004) (3)
The role of antibodies in liver graft-induced tolerance in mice: passive transfer of serum and effect of recipient B-cell depletion. (1995) (3)
Surgical Techniques for Orthotopic Liver Transplantation in Mice (1998) (3)
Resource use in liver transplantation. (1999) (3)
WHY SOME CHILDREN ARE STILL ON STEROID BEYOND FIVE YEARS POST LIVER TRANSPLANTATION UNDER TACROLIMUS (1999) (3)
Efficacy and Safety of Everolimus With Reduced Tacrolimus in De Novo Liver Transplant Recipients: Long-Term Results From the H2304E1 Study.: Abstract# A430 (2014) (3)
Notes on FK 506. (1991) (3)
Outcome of human islet isolation and allotransplantation in 20 consecutive cases. (1992) (3)
What Have We Learned About Primary Liver Transplantation Under Tacrolimus Immunosuppression? (1999) (3)
Post–Liver Transplantation Management (2010) (3)
HEPATITIS C VIRUS GENOTYPES IN LIVER TRANSPLANT RECIPIENTS (1997) (3)
An attempt to induce tolerance with infusion of donor bone marrow in organ allograft recipients. (1997) (3)
Immune complex disease in immunosuppressed rat recipients of hamster liver xenografts. (2001) (3)
Overview of FK 506 in transplantation (1992) (3)
Effect of serum on SmartFlare™ RNA Probes uptake and detection in cultured human cells. (2020) (3)
Evidence of microchimerism after pretransplant blood transfusion and FK 506 in liver xenograft. (2000) (3)
De novo anti-HLA antibodies have the highest incidence in the first year after transplantation (2003) (3)
Chronic hepatitis B virus infection is associated with impaired function of dendritic cells (2000) (3)
William Hunter Harridge lecture: The changing face of short-gut syndrome management. (2017) (3)
The protection from humoral rejection given by a liver xenograft is species-specific and non-MHC restricted. (1995) (3)
Liver transplantation for hepatitis B: what have we learned and what does the future hold? (1995) (3)
Posttransplant hypertension in blacks versus nonblacks. (1993) (3)
The Sleeping Giant Awakens—Liver Transplantation in China (2010) (3)
Quantitative assessment of the development of hepatoma in a buffalo rat model. (1997) (3)
Basic considerations for the procurement of intestinal grafts. (1994) (3)
Combined bone marrow and solid organ transplantation with alemtuzumab induction (2003) (2)
Between Scylla and Charybdis. (1995) (2)
Risk stratification of allograft failure secondary to hepatitis C recurrence after liver transplantation (2016) (2)
Long-term Stability of β-Cell Graft Function After Total Pancreatectomy and Islet Autotransplantation. (2021) (2)
Efficacy and safety of everolimus with early reduction or elimination of tacrolimus in 719 de novo liver transplant recipients: 12 month results of a phase iii, randomized, controlled study (2011) (2)
Islets Transplantation at a Crossroads - Need for Urgent Regulatory Update in the United States: Perspective Presented During the Scientific Sessions 2021 at the American Diabetes Association Congress (2022) (2)
Association of HLA Compatibility and Decreased Liver Transplant Survival. (1988) (2)
Outcome of kidney transplantation in African-Americans using tacrolimus. (1997) (2)
Hepatocytes or liver nonparenchymal cells plus FK 506 prolong liver xenograft survival. (1994) (2)
Cell migration, chimerism, and graft acceptance: with particular reference to the liver (2005) (2)
WEANING OF IMMUNOSUPPRESSION IN LIVER TRANSPLANT RECIPIENTS 1,2 (2010) (2)
Everolimus with reduced tacrolimus exposure versus standard tacrolimus in hepatitis C virus positive de novo liver transplant recipients. O-56. (2012) (2)
The patient with chronic hepatitis C. (1996) (2)
The role of Fas/FasL apoptotic pathway in the development of chronic rejection. (1999) (2)
12 Progression and treatment of recurrent hepatitis C after liver transplantation patietns co-infected with HIV (2003) (2)
CTLA4-Ig inhibits rejection of mouse liver allografts from Flt3-ligand-treated donors and is associated with increased lymphocyte apoptosis. (2001) (2)
Conversion of pediatric liver allograft recipients from Cyclosporin to Tacrolimus based immunosuppression: 4 to 8 years follow-up. (1998) (2)
Structural integrity and identification of causes of late liver allograft dysfunction in long surviving (greater than 5 years) recipients (1995) (2)
Neither amyloid depositions nor hepatic steatosis are associated with marginal islet mass early after autotransplantation (2020) (2)
Presentation of MHC-disparate donor antigens predominantly by the indirect pathway results in the development of posttransplant vasculopathy: salutary effects of perioperative costimulatory blockade. (2001) (2)
RABBIT ANTI-THYMOCYTE (RATG) PRECONDITIONING AND INDUCTION FOR PEDAITRIC INTESTINE TRANSPLANTATION (2004) (2)
A PROSPECTIVE RANDOMIZED TRIAL OF TACROLIMUS AND PREDNISONE VERSUS TACROLIMUS , PREDNISONE , AND MYCOPHENOLATE MOFETIL IN PRIMARY ADULT LIVER TRANSPLANT RECIPIENTS (2010) (2)
Comparison of the regulatory regions of the alpha1,3galactosyltransferase gene between murine and porcine species. (2001) (2)
Late intraocular pressure rise following intravitreal triamcinolone injection (2007) (2)
ADULT PRIMARY LIVER TRANSPLANTATION: PROSPECTIVE RANDOMIZE TRIAL OF TACROLIMUS AND STEROID VS TACROLIMUS, STEROID AND MYCOPHENOLATE MOFETIL (1998) (2)
Nuclear Hepatology: A Textbook of Hepatobiliary Diseases, 2nd ed., Gerbail T. Krishnamurthy, S. Krishnamurthy (Eds.). Springer, New York, New York (2009), 368 pp. $199.00. Web site for ordering: www.springer.com, ISBN: 9-7836-4200-6470 (2010) (2)
Breaking the Donor Age Barrier to Face the Organ Shortage in Liver Transplantion (1995) (2)
Potentiation of the antiproliferative activity of brequinar sodium for murine lymphocytes by exogenous cytidine. (1993) (2)
Congress Proceedings - First International Workshop. Neurological Problems and Liver Transplantation: Current perspective on immunosuppression used in liver transplantation with emphasis on neurotoxicity (1999) (2)
QUANTITATION OF IMMUNOSUPPRESSION BY FK506 USING FLOW CYTOMETRIC ANALYSIS OF IL‐2 AND INF‐&ggr; INHIBITION IN PERIPHERAL BLOOD T CELLS.: Abstract# 1081 (2000) (2)
Blockade of the CD28/B7 and CD40/CD40L costimulatory pathways does not ameliorate chronic rejection in a mouse aortic allograft model of direct antigen presentation. (2001) (2)
Neutralization of IL-12 reverses rejection of mouse liver allografts from Flt3-ligand-treated donors and is associated with suppression of both cellular and humoral responses. (2001) (2)
Modified temporary end‐to‐side portocaval shunt in liver and small bowel transplantation (2001) (2)
REVERSAL OF RENAL ACUTE CELLULAR REJECTION(ACR) USING THE MONOCLONAL ANTIBODY CAMPATH 1H(C 1H) (2004) (2)
A message from the incoming editors of Liver Transplantation (2005) (2)
Advances in hepatitis B virus infection. (2003) (2)
An isolated complete intestinal transplantation in an adult: A complicated postoperative course (1992) (2)
Outcome of kidney transplantation under tacrolimus-based immunosuppression in elderly patients. (1999) (2)
Expressive dysplasia possibly related to FK 506 in 2 liver transplantation recipients (1990) (2)
FcgammaRllc 13Q/STP polymorphism influences the antibody-dependent cytotoxicity levels triggered by natural killer cells against pig aortic endothelial cells. (2001) (2)
Survival of human hepatocellular aggregates in athymic mice. (1992) (2)
I-131 orthoiodohippurate assessment of renal function after heart transplantation. (1999) (2)
Xenogeneic humoral graft-Vs-host disease following hamster-to-Rat bone marrow transplantation. (2000) (2)
SUCCESSFUL REVERSAL OF REFRACTORY ACUTE REJECTION WITH CAMPATH 1H IN PANCREAS TRANSPLANTATION RECIPIENTS: 038 (2003) (2)
Perioperative treatment with phosphatidic acid inhibitor (Lisofylline leads to prolonged survival of hearts in the guinea pig to rat xenotransplant model. (1996) (2)
Effect of tacrolimus and splenectomy on engraftment and GVHD after bone marrow xenotransplantation in the reciprocal hamster to rat animal models. (1996) (2)
Post transplantation diabetes in pediatric recipients on tacrolimus (Letter) (1999) (2)
HBIG AND LAMIVUDINE AFTER LIVER TRANSPLANTATION FOR HEPATITIS B RELATED LIVER DISEASE.: Abstract# 767 Poster Board #‐Session: P24‐III (2000) (2)
A Novel NF-κB Enhancer Region Regulates Cytokine Induction Of The Human Inducible Nitric Oxide Synthase (iNOS) Gene Promoter (1998) (2)
A NEW TOLERGENIC IMMUNOSUPPRESSIVE STRATEGY FOR HUMAN INTESTINAL TRANSPLANTATION (2004) (2)
MORE THAN SIX YEARS ACTUAL FOLLOW-UP:CONVERSION FROM CYCLOSPORINE TO TACROLIMUS FOR CHRONIC LIVER ALLOGRAFT REJECTION (1999) (2)
BACTERIAL TRANSLOCATION IN INTESTINAL TRANSPLANT RECIPIENTS (1999) (2)
Kidney/Bone Marrow Transplantation. (1996) (2)
Liver Transplantation Using Pediatric Organ Donation After Circulatory Death - An Analysis of the National Registry.: Abstract# 2239 (2014) (2)
[Analysis of causes of late mortality in liver transplant recipients]. (2004) (2)
ADMINISTRATION OF A NEW SUBSET OF DENDRITIC CELLS PROPAGATED FROM MOUSE LIVERS PROLONGS CARDIAC ALLOGRAFT SURVIVAL BY DIFFERENTIATION OF T REGULATORY CELLS.: Abstract# 1094 (2000) (1)
Use of FK 506 in the treatment of liver allograft rejection (1991) (1)
LONG TERM RESULTS OF LIVER TRANSPLANTATION FOR ALCOHOLIC RELATED LIVER DISEASE UNDER TACROLIMUS (1999) (1)
Efficacy and Safety of Everolimus With Reduced Tacrolimus in De Novo Liver Transplant Recipients: Long-Term Results From the H2304E1 Study (2014) (1)
Mycophenolate mofetil for treatment of chronic rejection in liver allograft under tacrolimus. (2002) (1)
Evolution of Renal Function with Early Everolimus-Facilitated Reduction or Elimination of Tacrolimus in 719 De Novo Liver Transplant Recipients: 12 Month Data of the H2304 Study (2012) (1)
Clinical xenotransplantation (1994) (1)
Conversion from tacrolimus to cyclosporine--a based immunosuppression following liver transplantation. (2003) (1)
--------- / 67 7 " HUMAN INTESTINAL AND MUL TIVISCERAL TRANSPLANTATION " Three years clinical experience at the Pittsburgh Transplantation Institute (1)
Organ allocation in the United States: where does it stand? Point. (2001) (1)
Everolimus-Facilitated reduction of Tacrolimus provides comparble efficacy and superior renal function versus standard tacrolimus in de novo liver transplant recipients: 24-month results of a randomized trial (2012) (1)
Bone marrow augmentation in solid organ transplantation–any conclusions? (1995) (1)
Establishing an Ex-Vivo Pancreas Perfusion Model On Discarded Human Grafts.: Abstract# C2072 (2014) (1)
All-Trans Retinoic Acid Induces Arg-1 and iNOS Producing Dendritic Cells With T Cell Inhibitory Function.: Abstract# 585 (2014) (1)
THE EXPERIENCE WITH TACROLIMUS-BASED IMMUNOSUPPRESSION (1996) (1)
1402 EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS: 12 MONTH RESULTS OF A RANDOMIZED, CONTROLLED STUDY IN 719DE NOVO LIVER TRANSPLANT RECIPIENTS (2012) (1)
BETA-2 Score Allows for Convenient and Precise Monitoring of Islet Function and Early Detection of Islet Dysfunction (2018) (1)
Silencing of Stearoyl-CoA Desaturase Inhibits Proliferation and Induces Apoptosis in Human Hepatocellular Carcinoma: 378 (2008) (1)
LIVER TRANSPLANTATION IN CHILDREN WITH CIRRHOSIS AND HEPATOPULMONARY SYNDROME (1995) (1)
Differential CYP450 Isozyme Activity Following Orthotopic Liver Transplantation (OLTx) (1996) (1)
Surgical Complications in 275 Human Immunodeficiency Virus (HIV) Infected Liver and/or Kidney Transplant Recipients (2012) (1)
COMBINED LIVER-KIDNEY TRANSPLANTS: DO LIVERS ALWAYS PROTECT KIDNEYS IN ALLOSENSITIZED RECIPIENTS?: 1521 (2010) (1)
Everolimus With Reduced Tacrolimus Preserves Long-Term Renal Function in Liver Transplant Recipients: 36 and 48 Months Results From The H2304E1 Study.: Abstract# 2187 (2014) (1)
A Prospective Study on Conversion from Sandimmune to Neoral in Stable Adult Liver Transplant Recipients (1999) (1)
The pharmacodynamics of pentobarbital following FK 506 therapy. (1991) (1)
Prophylactic use of OKT3 in liver transplantation. A review. (1991) (1)
Idiotypy in Ontogeny of Phosphorylcholine-Specific Precursors (1981) (1)
PEDIATRIC LIVER RESOURCE UTILIZATION-CURRENT INEQUITIES AND POSSIBLE SOLUTIONS. A REVIEW OF THE UNOS SCIENTIFIC REGISTRY DATA-1991-1997 (1999) (1)
WEANING OF IMMUNOSUPPRESSION IN LONG-TERM LIVER TRANSPLANT RECIPmNTS1,2 (1995) (1)
129Incidence of of de novo cancer and posttransplant lymphoproliferative disorder after liver transplantation under tacrolimus comparitive study (2000) (1)
The lectin but not classical pathway of activation is important for complement to regulate the development of experimental autoimmune uveitis (2016) (1)
Comparison of alpha-interferon alone and alphainterferon and ribavirin for the treatment of recurrent hepatitis C after liver transplantation (2000) (1)
Haemostasis in liver transplantation surgery (2007) (1)
Painting factor H onto mesenchymal stem cells protects the cells from complement- and neutrophil-mediated damage (2016) (1)
Prolongation of allograft survival in the BN rat with mercuric chloride autoimmune disease (1994) (1)
Hepatitis B virus (HBV) re-infection following liver transplantation: theory and practice. (1995) (1)
ADMINISTRATION OF ANTISENSE OLIGODEOXYRIBONUCLEOTIDES AGAINST mRNA OF CD80 OR CD86 PROLONGS SURVIVAL OF CARDIAC ALLOGRAFTS BY INHIBITION OF T CELL ACTIVATION.: Abstract# 315 Poster Board #‐Session: P162‐I (2000) (1)
Hemophilia Liver Transplant Observational Study (HOTS) (2016) (1)
IS-23 Rabbit anti-thymocyte (rATG) preconditioning and induction for pediatric Intestinal transplantation(International Session V) (2004) (1)
IMMUNOMONITORING IN ALLOGRAFT RECIPIENTS TREATED WITH A TOLERANCE-ENHANCING IMMUNOSUPPRESSIVE REGIMEN (2004) (1)
PRIMARY LIVER TRANSPLANTATION UNDER TACROLIMUS IN INFANTS, CHILDREN, ADULTS AND SENIORS: 1000 CONSECUTIVE PATIENTS FROM SINGLE CENTRE WITH 5 TO 8 YEARS ACTUAL FOLLOW-UP (1998) (1)
Administration of CTLA4-Ig enhances the incidence of hamster-to-rat xenogeneic bone marrow engraftment and alters the presentation of graft-vs-host disease. (2000) (1)
Xenotransplantation of hamster liver into Gunn rats reserves congenital hyperbilirubinemia. (1996) (1)
Highlights of the Festschrift in Honor ofThomas E. Starzl, MD, PHD (2002) (1)
ROLE OF HUMAN HERPESVIRUS‐6 IN THE PATHOGENESIS OF FUNGAL INFECTIONS AND IMPACT ON OUTCOME IN LIVER TRANSPLANT RECIPIENTS.: Abstract# 1126 (2000) (1)
119-OR: Total Pancreatectomy with Islet Autotransplantation in Diabetic and Prediabetic Patients with Intractable Chronic Pancreatitis (2020) (1)
Spindle Cell Tumor of the Portal Vein (2011) (1)
28 Impact of Ulcerative Colitis on the Long Term Outcome of Patients With Primary Sclerosing Cholangitis (2012) (1)
The antibody cross match in liver transplantation (2010) (1)
Documentation in bone-marrow-augmented organ recipients of the presence of dendritic cell progenitors of donor origin. (1997) (1)
World's longest surviving liver‐pancreas recipient (2007) (1)
Use of OKT 3 with Ciclosporin and Steroids for Reversal of Acute Kidney and Liver Allograft Rejection (2010) (1)
The effect of thymus transplantation on allograft rejection in thymectomized bone marrow chimeras. (1990) (1)
Therapeutic potential of staphylococcal superantigen-like protein 7 for acute complement activation mediated diseases (2016) (1)
Stereotactic Radiation (SBRT) for Primary Liver Malignancies (2012) (1)
AN ANALYSIS OF EARLY RENAL TRANSPLANT PROTOCOL BIOPSIES ‐ THE HIGH INCIDENCE OF SUBCLINICAL ACUTE REJECTION.: Abstract# 972 (2000) (1)
Everolimus with early reduction or elimination of tacrolimus in 719 de novo liver transplant recipients - 12 month efficacy and safety results from the H2304 study (2012) (1)
Evidence for Deletion of Cytotoxic T Cells and Implications for Tolerance (1997) (1)
PORTAL VERSUS SYSTEMIC VENOUS DRAINAGE OF INTESTINAL ALLOGRAFTS IN HUMANS (1998) (1)
Xenoreactivity in mouse + rat-->mouse chimeras. (1993) (1)
Liver transplantation for fatty liver disease (2011) (1)
Adenoviral Vectors Encoding CTLA 4-Ig Oligodeoxyribonucleotide Decoys and B κ Engineered with NF-Survival by Dendritic Cells Genetically Marked Prolongation of Cardiac Allograft and (2002) (1)
Simultaneous pancreas-kidney transplantation at the University of Pittsburgh. (1999) (1)
Wound healing events and arterial complications with everolimus versus tacrolimus based regimens in de novo liver transplant recipients. O-22 (2012) (1)
Islet transplantation in diabetes: The Pittsburgh experience (1992) (1)
Transfection with genes encoding CTLA4Ig mediated by adenoassociated virus vectors prolongs survival of heart allografts. (2001) (1)
ADJUVANT DONOR BONE MARROW INFUSION IN ORGAN TRANSPLANT RECIPIENTS IS ASSOCIATED WITH REDUCED INCIDENCE OF ACUTE AND CHRONIC REJECTION (1999) (1)
459 IL-2 Receptor Antagonist (Il2-RA), Basiliximab, Is Associated with Rapid Fibrosis Progression in Patients with Recurrent Hepatitis C Virus (HCV) After Liver Transplantation (LT) Using Serial Biopsy Specimens (2008) (1)
Studies of the hepatotrophic qualities of FK 506 and cyclosporine (1990) (1)
Long-term follow up of a double-blind, randomized, placebo-controlled trial of Cyclosporine Inhalation Solution (CyIS) in lung transplant recipients (2005) (1)
The H2304E1 Study: Efficacy and Safety of Everolimus With Reduced Tacrolimus Versus Standard Tacrolimus in De Novo Liver Transplant Recipients at 36 Months. (2014) (1)
Reversal of Protein-Losing Enteropathy after Liver Transplantation in a Child with Idiopathic Familial Neonatal Hepatitis: 572 (2008) (1)
Survival of the sickest. Organ allocation should be based on patients' medical need, not location. (1998) (1)
Concordant hamster-to-rat liver xenotransplantation leads to hyperlipidemia. (2000) (1)
Surgical Procedures on the Cirrhotic Patient (2017) (1)
Mechanisms underlying the development of T-cell tolerance following interruption of signalling at the CD28/B7 and CD40/gp39 interface. (1999) (1)
ADENOVIRAL-MEDIATED DELIVERY OF THE HUMAN iNOS GENE TO LIVER ISOGRAFTS: AN IMPROVED MODEL OF EX-VIVO GENE TRANSFER (1998) (1)
"SUBOPTIMAL" KIDNEY DONORS (2010) (1)
Animal Activism and Intimidation of Scientists (2006) (1)
REASONS FOR LONG-TERM STEROID USE FOLLOWING PRIMARY ADULT LIVER TRANSPLANTATION UNDER TACROLIMUS (1999) (1)
Prevention of sensitization and hyperacute rejection in liver and heart xenografts by FK 506 plus donor antigens. (1995) (1)
Call for an End to Unethical Transplant Practices: A Concerted Effort by the Transplant Community. (2019) (1)
Comparative study of pharmacokinetic profile following intravenous infusion of tacrolimus in pediatric and adult liver transplant recipients (1995) (1)
Cytidine potentiates the inhibitory effect of brequinar sodium on concordant cardiac xenograft rejection. (1994) (1)
Can partial auxiliary liver transplantation protect kidney grafts in highly sensitized patients? (2007) (1)
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD) FOLLOWING ADULT LIVER TRANSPLANTATION: RETROSPECTIVE STUDY OF OVER 4000 PATIENTS OVER 15 YEARS FROM SINGLE CENTER: PTLD following successful transplantation has remained a major concern both in children and adults. (1999) (1)
THYMOGLOBULIN PRECONDITIONING AND TACROLIMUS MONOTHERAPY WITH SUBSEQUENT WEANING IN RENAL TRANSPLANT RECIPIENTS: AN UPDATE (2004) (1)
Acute Pancreatis in Renal Transplant Recipients under Tacrolimus Immunosuppression (1999) (1)
LONG TERM IMPACT OF STEATOTIC DONOR LIVERS IN PATIENTS WITH HEPATITIS C (2004) (0)
Liver Transplantation Using Anti-HBc Positive Donors: A Single Center Experience.: Abstract# B1127 (2014) (0)
The Impact of DAA in Changing the Face of Liver Transplantation (2017) (0)
Renal Benefit With Everolimus (EVR) and Reduced Tacrolimus (TAC) vs Standard TAC Is Maintained to 3 Years After Liver Transplantation in North America (NA).: Abstract# A427 (2014) (0)
Transplant Tolerance and Myeloid Supressor Cells: 1325 (2012) (0)
LONG-TERM FOLLOW-UP AFTER LIVER TRANSPLANTATION FOR ALCOHOLIC LIVER DISEASE UNDER TACROLIMUS1 (2000) (0)
UTILIZATION OF LIVERS FROM CONTROLLED NON-HEARTBEATING DONORS (NHBD)- A SINGLE CENTER EXPERIENCE ON 55 LIVER TRANSPLANTS OVER A 10-YEAR PERIOD (2004) (0)
Everolimus-Facilitated Reduction of Tacrolimus in De Novo Liver Transplant Recipients Achieves Comparable Overall Efficacy with Fewer Biopsy-Proven Acute Rejections Versus Standard Tacrolimus: 24-Month Results of a Randomized Trial (2013) (0)
T CELL ANERGY BUT NOT DELETION IS THE PREDOMINANT MECHANISM FOR INDEFINITE ISLET ALLOGRAFT SURVIVAL IN RECIPIENTS TREATED WITH rhCTLA4-Ig AND ??-gp39 ANTIBODY (1998) (0)
P0047 : Recipient (but not donor) adiponectin polymorphisms are associated with post transplant hepatic steatosis (2015) (0)
INTESTINAL TRANSPLANTATION AND BONE MARROW AUGMENTATION.: Abstract# 754 Poster Board #‐Session: P11‐III (2000) (0)
69 Pathology of Liver Transplantation (2010) (0)
INHIBITION OF IN VITRO DONOR‐SPECIFIC PROLIFERATION AND CYTOTOXIC T CELL RESPONSES IN CHIMERIC CD40L‐/‐ BONE MARROW TRANSPLANT RECIPIENTS TREATED PERIOPERATIVELY WITH hCTLA4‐Ig.: Abstract# 657 (2000) (0)
Arterial Intimal Fibrosis in Reperfusion Biopsy Correlates with Graft Function after Kidney Transplant (2021) (0)
THE USE OF RAG-2 DEFICIENT MICE TO ASCERTAIN THE ROLE OF CELLULAR AND HUMORAL IMMUNE RESPONSES IN THE DEVELOPMENT OF CHRONIC REJECTION (1999) (0)
TACROLIMUS IN PEDIATRIC RENAL TRANSPLANTATION 1 (2010) (0)
LONG TERM OUTCOME OF HEPATITIS C VIRAL (HCV) INFECTION IN PRIMARY ADULT LIVER TRANSPLANT RECIPIENTS COMPARED TO NON HCV UNDER TACROLIMUS (1999) (0)
Plasma Vascular Endothelial Growth Factor (VEGF) Predicts Vascular Invasion in Patients with Hepatocellular Carcinoma (HCC) Undergoing Liver Transplantation.: Abstract# B3025 (2014) (0)
Immunosuppression in Composite Tissue Allotransplantation (2011) (0)
HCV genotypes and outcome in HCV infected cirrhotic patients receiving liver transplant from HCV positive donors (1995) (0)
TRANSPLANT VASCULAR SCLEROSIS: FROM PATHOGENESIS TO PREVENTION (2010) (0)
OR.83. Immune Inhibitory Activity of Liver Tissue Cells and Application in Improving Cell Transplantation (2006) (0)
P866 EVEROLIMUS-BASED IMMUNOSUPPRESSION PROVIDES SUPERIOR RENAL FUNCTION AND COMPARABLE EFFICACY VERSUS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANTATION: 3-YEAR RESULTS FROM H2304 STUDY EXTENSION (2014) (0)
Liver transplantation for hepatitis B and C (2002) (0)
COMBINED SIMULTANEOUS BLOCKADE OF CD28/27 AND CD40/CD40L COSTIMULATORY PATHWAYS RESULTS IN LONG-TERM ACCEPTANCE OF PANCREATIC ISLET ALLOGRAFTS (1998) (0)
CYTOKINE-STIMULATED HUMAN INDUCIBLE NITRIC OXIDE SYNTHASE (iNOS) GENE EXPRESSION IS MEDIATED BY ACTIVITY OF TRANSCRIPTION FACTORS NF-??B AND STAT1?? (1999) (0)
Recent Advances in Hepatic Transplantation at (1993) (0)
INTESTINAL TRANSPLANTATION.: Abstract# 98 (2000) (0)
A PROSPECTIVE RANDOMIZED TRIAL OF FK506 VERSUS CYCLOSPORINE AFTER HUMAN PULMONARY TRANSPLANTATION1 (1994) (0)
Influence of Prolonged Harvesting Time during Organ Procurement on Early Graft Outcome in Human Liver Transplantation (肝移植における臓器摘出時間延長の術後早期移植片機能に及ぼす影響) (2000) (0)
Mouse liver allograft rejection correlates with enhanced TH1 function (1994) (0)
A NOVEL APPROACH TO GENERATE (EX VIVO) EBV-SPECIFIC CYTOTOXIC T CELLS FROM A NAÏVE IMMUNOCOMPETENT EBV-NEGATIVE INDIVIDUAL (1999) (0)
INTESTINAL TRANSPLANTATION FOR PATIENTS WITH VISCERAL VASCULAR OCCLUSIVE DISEASE (1999) (0)
Sa.117. Laboratory Immunology@A Critical Role of B7-H1 in Protection of Islet Allografts By Co-Transplanted Hepatic Stellate Cells (2006) (0)
Producing Dendritic Cells with T Cell - and Inducible Nitric Oxide Synthase Retinoic Acid Induces Arginase-1 trans All- (2014) (0)
PATTERNS OF CMV ANTIGENEMIA AND DISEASE IN CMV-SERONEGATIVE LIVER RECIPIENTS TREATED WITH PREEMPTIVE GANCICLOVIR (1999) (0)
Liver transplantation in patients with transjugular intrahepatic portosystemic shunt. (1992) (0)
Induction Therapy With Antithymocyte Globulin and Delayed Calcineurin Inhibitor Initiation for Renal Protection in Liver Transplantation: A Multicenter Randomized Controlled Phase II-B Trial (2021) (0)
NEUTRALIZATION OF IL‐12 REVERSES REJECTION OF MOUSE LIVER ALLOGRAFTS FROM Flt3‐LIGAND‐TREATED DONORS AND IS ASSOCIATED WITH SUPPRESSION OF BOTH CELLULAR AND HUMORAL RESPONSES.: Abstract# 1149 (2000) (0)
Impact of Donor Cause of Death on Hepatic Arterial Flow in Liver Transplant Recipients: 3053 (2010) (0)
FasL (CD95L) DEFICIENCY AND ITS IMPACT ON THE PATHOGENESIS OF POSTTRANSPLANT ARTERIOSCLEROSIS (1998) (0)
Post-sclerotherapy esophageal perforations in liver transplant patients (1993) (0)
Liver transplantation: Future developments including xenotransplantation (1994) (0)
TYPE-1 POLARIZATION OF CD8+ T CELL RESPONSES AGAINST EBV ANTIGENS IS PRESERVED IN IMMUNOSUPPRESSED STABLE SOLID ORGAN TRANSPLANT RECIPIENTS (2004) (0)
Intestinal and multivisceral transplantation: More than a decade of a single center experience0 (2003) (0)
Pediatric liver transplantation: A Single Center Experience Spanning 20 Years1 (2002) (0)
LOCAL DELIVERY OF MYELOID DERIVED SUPRESSOR CELLS (MDSC) TO INDUCE HYPORESPONSIVENESS FOR CELL TRANSPLANTS: 2687 (2010) (0)
THE EFFECTS OF BLOCKADE OF CD28/B7 COSTIMULATORY PATHWAY AND DONOR BONE MARROW TRANSPLANTATION ON THE DEVELOPMENT OF CHRONIC REJECTION (1999) (0)
A Comparison of Laparoscopic Versus Open Techniques for Major and Minor Liver Resections (2013) (0)
Hepatic Stellate Cells Expand CD4+CD25+Foxp3+ Tregs and Prevent Rejection of Allogeneic Islet Transplants (2007) (0)
EPOPROSTENOL IS NOT A PANACEA FOR THE TREATMENT OF PORTO-PULMONARY HYPERTENSION (1999) (0)
Interferon-α And Ribavirin Treatment Of Recurrent Hcv After Liver Transplantation In Patients With Hiv And Hcv Co-infection (2004) (0)
DRUG METABOLISM IN OLDER OLTx PATIENTS: EFFECTS OF DONOR AND RECIPIENT AGE. (1999) (0)
En bloc liver and pancreas transplantation after total pancreatectomy with autologous islet transplantation (2020) (0)
Liver transplantation under FK 506 immunosuppression in elderly patients. (1994) (0)
GASTROINTESTINAL BLEEDING AFTER LIVER TRANSPLANTATION1 (2010) (0)
IN VIVO EVIDENCE: THE ROLE OF COMPLEMENT COMPONENT 3 (C3) IN INDUCTION OF MYELOID-DERIVED SUPPRESSOR CELLS (MDSC): 2712 (2010) (0)
BLOCKADE OF THE CD28/B7 AND CD40/CD40L COSTIMULATORY PATHWAYS DOES NOT AMELIORATE CHRONIC REJECTION DEVELOPING IN A MOUSE AORTIC ALLOGRAFT MODEL OF DIRECT ANTIGEN PRESENTATON.: Abstract# 897 Poster Board #‐Session: P154‐III (2000) (0)
SUPPRESSION OF DC ALLOIMMUNOGENICITY BY SYNTHETIC ALLOTRAP PEPTIDES. (1999) (0)
A PROSPECTIVE RANDOMIZED TRIAL OF TACROLIMUS AND PREDNISONE VERSUS TACROLIMUS , PREDNISONE AND MYCOPHENOLATE MOFETIL IN PRIMARY ADULT LIVER TRANSPLANTATION : A SINGLE CENTER REPORT 1 (2010) (0)
Establishing an Ex-Vivo Intestine Perfusion Model Utilizing Pig Grafts (2015) (0)
A NOVEL PORCINE MODEL OF IN SITU SUB-TOTAL (70%) DONOR HEPATECTOMY AND ORTHOTOPIC TRANSPLANTATION (Tx) OF THE REMAINING LIVER GRAFT. (1999) (0)
A NOVEL PATHWAY OF IMMUNOSUPPRESIVE ACTIVITY OF RAPAMYCIN: SPECIFIC INHIBITION OF IL-12-MEDIATED STAT4 PHOSPHORYLATION IN DDRITIC CELLS (2004) (0)
ADULT RESPIRATORY DISTRESS SYNDROME SECONDARY TO END‐STAGE LIVER DISEASE—SUCCESSFUL OUTCOME FOLLOWING LIVER TRANSPLANTATION1 (1993) (0)
Functional studies of in vivo committed lymphocytes propagated from organ transplants. (1986) (0)
A COMPARATIVE EVOLUTION OF EX-SITU AND IN-SITU SPLIT LIVER TRANSPLANTATION - THE PITTSBURGH EXPERIENCE (1999) (0)
Induction With Anti-Thymocyte Globulin (r-ATG) and Delayed Calcineurin Inhibitor Therapy in Patients With Acute Renal Failure Dysfunction Pre-Liver Transplant Allows for Sustained Renal Recovery Post Transplant.: Abstract# A428 (2014) (0)
INDUCTION OF CD8+ EFFECT T CELL APOPTOSIS BY CO-TRANSPLANT WITH HEPATIC STELLATE CELLS, A NOVEL APPROACH TO PROTECT ISLET ALLOGRAFTS: 206 (2008) (0)
HUMAN HERPESVIRUS‐6 (HHV‐6) INFECTION AND MENTAL STATUS CHANGES OF UNIDENTIFIABLE ETIOLOGY IN LIVER TRANSPLANT RECIPIENTS.: Abstract# 1128 (2000) (0)
MATURATIONAL ARREST OF DENDRITIC CELLS BY BLOCKADE OF NF‐KB WITH DECOY OLIGODEOXYRIBONUCLEOTIDES: POTENTIATION OF DENDRITIC CELL TOLEROGENICTY.: Abstract# 1148 (2000) (0)
Intestinal Stomas and the Biliary Tree (2012) (0)
OR.47. Impact of Organ Stromal Cells on Antigen-presenting Cell Development (2009) (0)
IMMUNE INHIBITORY ACTIVITY OF LIVER STELLATE CELLS IS MEDIATED BY INDUCIBLE EXPRESSION OF B7-H1 (2006) (0)
Normothermic Machine Perfusion (NMP) Promotes Early Graft Function and Biliary Epithelial Regeneration After Transplantation of Porcine Livers Undergoing 1hr Warm Ischemia (WI).: Abstract# A5 (2014) (0)
PROLONGATION OF ORGAN ALLOGRAFT SURVIVAL BY SYSTEMIC ANTI-IL-10 ANTIBODY ADMINISTRATION IS MEDIATED BY B CELL SUPPRESSION (1998) (0)
Use of Tacrolimus (FK506) and Antimetabolites as Immunosuppressants for Xenotransplantation Across Closely Related Rodent Species (1997) (0)
DC1-Based Protocols for Adoptive Immunotherapy for PTLD Boost Type-1 Anti-EBV CD8+ T Cell Responses in Solid Organ Tranplant Patients (2004) (0)
Orthothpic liver transplantation in US veterans under primary tacrolimus (PrografΓäó) immunosuppression (1996) (0)
RATE OF POST TRANSPLANT LYMPHO PROLIFERATIVEDISORDERS (PTLD) IN CHILDREN UNDER CYCLOSPORINE AND TACROLIMUS, 766 CONSECUTIVE RECIPIENTS: 15 YEARS EXPERIENCE.: Abstract# 787 Poster Board #‐Session: P44‐III (2000) (0)
DYNAMICS AND CLINICAL SIGNIFICANCE OF ANTI-HLA ALLOANTIBODIES IN SOLID ORGAN TRANSPLANTATION (2004) (0)
Delayed islet cell transplantation to reverse type I diabetes in humans (1996) (0)
Retransplantation ? The only means to save recipient's life after failure of liver transplantation: a report of 774 cases (2002) (0)
Clinical intestinal transplantation: improved long-term survival (2000) (0)
PRESENTATION OF MHC‐DISPARATE DONOR ANTIGENS PREDOMINANTLY BY THE INDIRECT PATHWAY RESULTS IN THE DEVELOPMENT OF POST‐TRANSPLANT VASCULOPATHY: SALUTORY EFFECTS OF PERIOPERATIVE CO‐STIMULATORY BLOCKADE.: Abstract# 729 (2000) (0)
XENOGENEIC HUMORAL GRAFT-VS-HOST DISEASE FOLLOWING HAMSTER TO RAT BONE MARROW TRANSPLANTATION (1999) (0)
Development of autologous C5 vaccines to block complement activity in vivo (2016) (0)
Assessing priorities and prognoses with prism scores in children receiving multiple (≥2) simultaneous abdomominal organ transplants (1999) (0)
COTRANSPLANTATION WITH LIVER STROMAL CELLS PROTECTS ISLET ALLOGRAFTS VIA INDUCTION OF MYELOID DERIVED SUPPRESSOR CELLS (MDSC): 2610 (2010) (0)
Erratum: (Cell Transportation (1999) 8:2 (198)) (2000) (0)
COMBINED USE OF TACROLIMUS (FK506) AND LEFLUNOMIDE (LEF) RESULTS IN PROLONGATION OF PANCREATIC ISLET ALLOGRAFT SURVIVAL (1998) (0)
MHC class I, not class II, play main roles in sensitization (1994) (0)
Comparative Evaluation of Simple Indices Using a Single Fasting Blood Sample to Estimate Beta Cell Function after Total Pancreatectomy with Islet Autotransplantation (2018) (0)
A new technique for hepatic parenchymal transection using an articulating 5 cm radiofrequency device: results from the first 100 cases (2017) (0)
BOTH HEPATOCYTES AND LIVER NON-PARENCHYMAL CELLS ARE INDUCERS OF APOPTOSIS IN ACTIVATED T CELLS (1998) (0)
Simultaneous infusion of donor bone marrow at the time of whole organ transplantation (1994) (0)
MECHANISTIC STUDIES ON DC-INDUCED T CELL HYPORESPONSIVENESS USING A TCR TRANGENIC MODEL (2004) (0)
WS-15-KL Moving from living-donor to deceased-donor transplantations in Japan(WS ワークショップ,第113回日本外科学会定期学術集会) (2013) (0)
Outcome of Locoregional Therapy for Hepatocellular Carcinoma (HCC) Before Liver Transplantation (2011) (0)
Thomas Earl Starzl (1926–2017) (2017) (0)
COMPARISON OF EARLY GRAFT FUNCTION AND COMPLICATIONS OF PANCREAS TRANSPLANT RECIPIENTS IN HISTIDINE‐TRYPTOPHAN‐KETOGLUTARATE‐HTK SOLUTION AND UNIVERSITY OF WISCONSIN (UW) SOLUTIONS.: 030 (2003) (0)
FK506 sensitivity profiles of in vitro activated T cells from organ transplant recipients (1994) (0)
Relationship of cytokine gene polymorphism to the post-transplant outcomes (2001) (0)
Cytomegalovirous infection in liver transplant recipients; detection of early antigenemia (pp65) in peripheral blood leukocytes and preemptive therapy. (1998) (0)
Obituary: The Impact of Thomas Earl Starzl, MD, PhD. (2017) (0)
IMMUNE MODULATION IN ORGAN RECIPIENTS BY SINGLE OR MULTIPLE DONOR BONE MARROW INFUSIONS (1998) (0)
HEPATIC ARTERY COMPLICATION FOLLOWING PRIMARY LIVER TRANSPLANTATION IN ADULTS AND CHILDREN: 1000 CONSECUTIVE CASES UNDER TACROLIMUS (1999) (0)
ORTHOTOPIC LIVER TRANSPLANTATION IN HIGH-RISK PATIENTS (2010) (0)
CHRONIC REJECTION OF THE INTESTINAL ALLOGRAFT.: Abstract# 203 Poster Board #‐Session: P50‐I (2000) (0)
SP-2-4 Considering the future education of young surgeons (2013) (0)
Combined Liver-Islet Allotransplantation (2006) (0)
BRIEF COMMUNICATIONS EVIDENCE FOR ENGRAFTMENT OF HUMAN BONE MARROW CELLS IN NON-LETHALLY IRRADIATED BABOONS l (0)
57 Bile duct complication following liver transplantation in adults and children: 1000 consecutives patients (2000) (0)
Serial in vitro studies in bone marrow augmented liver transplant recipients (1994) (0)
MONOSEGMENTAL BILE DUCT OCCLUSION AFTER SPLIT LIVER TRANSPLANTATION (1999) (0)
Resection Versus Laparoscopic Radiofrequency Thermal Ablation of Small Solitary Colorectal Liver Metastasis (2013) (0)
1 Enteric-Drained Pancreas Transplants Monitored by Fine-Needle Aspiration Biopsy (2010) (0)
CO-TRANSPLANTED HEPATIC STELLATE CELLS PROTECT ISLET ALLOGRAFTS FROM REJECTION THROUGH A LOCAL IMMUNOSUPPRESSIVE MECHANISM. (2006) (0)
Incidence and Severity of Acute Allograft Rejection in Liver Transplant Recipients Treated With Alfa lnterferon (2010) (0)
Thomas E. Starzl, M.D., Ph.D. (1926-2017). (2017) (0)
Su1070 Safety and Efficacy of Telaprevir-Based Triple Therapy to Treat HCV Recurrence Post-Liver Transplantation (2014) (0)
Steroid-Sparing Immunosuppressive Protocols and Their Impact on Infections (2005) (0)
CYTOTOXICITY OF LAK CELLS AND EBV-SPECIFIC T CELLS AGAINST LYMPHOBLASTOID EBV-POSITIVE B CELLS: A MODEL FOR CELLULAR THERAPY OF PTLD (1998) (0)
443 Robotic Liver Tumor Resection (2009) (0)
Liver , Kidney , and Thoracic Organ Transplantation (2005) (0)
Liver Surgery in Patients With Inflammatory Bowel Disease (2019) (0)
NEW PARP INHIBITOR GPI 15427 PREVENTS PRIMARY HEART NONFUNCTION (PNF) OF BORDERLINE-PRESERVED RAT HEART GRAFTS (2004) (0)
DURABLE EFFECT OF BETA CELL REPLACEMENT THERAPY ON IMPROVEMENT IN BLOOD GLUCOSE CONTROL AND PREVENTION OF PROGRESSION OF SECONDARY DIABETIC COMPLICATIONS IN NONUREMIC PATIENTS WITH TYPE 1 DIABETES MELLITUS AND PROBLEMATIC HYPOGLYCEMIA (2020) (0)
PLASMACYTOID DENDRITIC CELLS PREVENT DEVELOPMENT OF TYPE 1 DIABETES IN NOD MICE (2004) (0)
HEPATIC STROMAL CELLS EXERT IMMUNE INHIBITORY ACTIVITY VIA INDUCTION OF MYELOID-DERIED SUPPRESSOR CELLS (MDSC): 2477 (2010) (0)
THE TEMPORAL RELATIONSHIP BETWEEN THE CELLULAR AND HUMORAL IMMUNE RESPONSES IN THE PATHOGENESIS OF TRANSPLANT VASCULAR SCLEROSIS (1999) (0)
Deficiency of complement anaphylatoxin receptors leads to ameliorated experimental autoimmune uveitis (2015) (0)
A useful technique for both allogenic and xenogenic orthotopic liver transplantation in rats (1999) (0)
ALLOTRAP1258 INHIBITS CHRONIC REJECTION BY DIRECT EFFECTS ON SMOOTH MUSCLE CELLS. (1999) (0)
A matched comparison of liver resection and laparoscopic radiofrequency ablation for colorectal liver metastases based on tumor burden and ASA status (2017) (0)
Future developments in liver treansplantation (2003) (0)
ENHANCEMENT OF IMMATURE DENDRITIC CELL TOLEROGENICITY BY ADMINISTRATION OF ANTI-CD40 LIGAND mAb IS ASSOCIATED WITH T CELL APOPTOSIS NOT INHIBITION OF B7 MOLECULE EXPRESSION (1998) (0)
Loss of serum bicarbonate after discordant liver xenotransplantation. (2000) (0)
Clinical Transplantation and the Immunology of Organ Rejection (2002) (0)
Transplant Graft Has Potential to Counterattack Host Immune Response: Exploring Underlying Cellular and Molecular Mechanisms.: Abstract# D2791 (2014) (0)
SYSTEMIC ADMINISTRATION OF CTLA4‐Ig INHIBITS REJECTION OF LIVER ALLOGRAFTS OF Flt3‐LIGAND‐TREATED DONOR MICE: ASSOCIATION WITH INCREASED LYMPHOCYTE APOPTOSIS.: Abstract# 713 (2000) (0)
A clinical trial of intrathymic inoculation of donor bone marrow cells with concomitant pediatric heart transplantation: preliminary observations. (1999) (0)
OR12 Monitoring CD8+ donor lymphocyte chimerism is a critical indicator for diagnosing and treating acute graft vs. host disease following liver transplantation (2018) (0)
P0991 : Recipient and donor adiponectin polymorphisms are not associated with new onset diabetes after liver transplantation (2015) (0)
HEPATIC STELLATE CELLS MORE EFFECTIVELY PROTECT ISLET ALLOGRAFTS THAN BONE MARROW-DERIVED MESENCHYMAL STEM CELLS: 307 (2008) (0)
Honorary chief editor (2013) (0)
Oral Abstracts – Liver Session (2004) (0)
The Relative Effects of Increased Regulatory Oversight and Public Reporting On Kidney Transplant Volume.: Abstract# B1203 (2014) (0)
THE IMPACT OF RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION (LTx) IN HIV AND HCV CO-INFECTED PATIENTS. (2006) (0)
TPA in DCD AJT 2010 (2013) (0)
Re: Association Between Renal Dysfunction and Major Adverse Cardiac Events After Liver Transplantation: Evidence From an International Randomized Trial of Everolimus-Based Immunosuppression (2019) (0)
Sa1379 WHAT IS A BENEFIT OF ISLET AUTOTRANSPLANTATION IN DIABETIC AND PREDIABETIC PATIENTS SUBMITTED TO TOTAL PANCREATECTOMY FOR CHRONIC PANCREATITIS WITH INTRACTABLE PAIN? (2020) (0)
PREVENTION OF DIABETES DEVELOPMENT IN NOD MICE BY DUALLY MODIFIED DENDRITIC CELLS DEFICIENT IN NF-&kgr;B AND OVEREXPRESSION OF IL-10 (2004) (0)
Community Risk Factors: Powerful Independent Predictors of Kidney Transplant Recipient Outcomes: 2256 (2012) (0)
Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease (2003) (0)
Reconstruction of an abnormal hepatic vein in a donor liver: a case report. (1998) (0)
Sa1632 Liver Transplantation Indications and Outcomes in Young Adults in the United States (2016) (0)
Su1010 Recipient (but Not Donor) Adiponectin Polymorphisms Are Associated With Post Transplant Hepatic Steatosis (2015) (0)
Characteristics of women with uterine factor infertility seeking information on uterine transplantation (2016) (0)
Chapter 88 – Leukocyte Chimerism—Meaning and Consequences (2015) (0)
110Causes of death after liver transplantation (LTx) in 4000 consecutive patients: Median followup 15 years (2000) (0)
Prophylactic Use of OKT 3 in Liver Transplantation / / ' 1 , 8 A Review (2010) (0)
4-P : COMPLEMENT FIXING DONOR-SPECIFIC ANTIBODIES IDENTIFIED BY THE C1q ASSAY IN COMBINED LIVER-KIDNEY TRANSPLANTS WITH AMR (2013) (0)
Is Mallory's body a prognostic factor in the outcome after liver transplantation in patients with alcoholic cirrhosis? (1995) (0)
DIFFERENTIAL EFFECTS OF DENDRITIC CELLS OVEREXPRESSING MAMMALIAN IL-10 ON ORGAN ALLOGRAFT AND ANTI-TUMOR IMMUNITY (1999) (0)
LIVER STELLATE CELLS, AS NON-PROFESSIONAL ANTIGEN-PRESENTING CELLS, PREFERENTIALLY EXPAND TREG CELLS IN AN IL-2 DEPENDENT MANNER: 2214 (2008) (0)
Liver transplantation: Current management - Preface (1999) (0)
94 Outcome of liver transplantation for hemophiliacs and HCV, with or without HBV & HIV infection under tacrolimus. Nine years experience from a single center (2000) (0)
INHIBITION OF DENDRITIC CELL DIFFERENTIATION AND MATURATION BY SOLUBLE FACTOR (S) PRODUCED BY LIVER STELLATE CELLS: 1501 (2008) (0)
475 Increased Serum Levels of Carbohydrate Antigen 19-9 in Primary Sclerosing Cholangitis is Associated With Reduced Survival Even in Patients Without Cholangiocarcinoma (2012) (0)
Experience With Everolimus Following Calcineurin Inhibitor Withdrawal in Liver Transplant Recipients.: Abstract# A446 (2014) (0)
PERCUTANEOUS ULTRASOUND GUIDED PANCREAS ALLOGRAFT BIOPSY SINGLE CENTER EXPERIENCE.: 035 (2003) (0)
164 A Historical Cohort Study Comparing the Clinical Outcome of Ulcerative Colitis and Crohn's Disease in the Presence of Primary Sclerosing Cholangitis (2012) (0)
Role of HLA Class II-Specific Alloreactive T Cells in Biliary Epithelium Injury Associated with Liver Transplant Rejection (1989) (0)
Outcome of Kidney Transplantation under Tacrolimus-Based Immunosuppression in Elderly Patients (1999) (0)
Infection Hepatitis C Virus and Renal Failure (2003) (0)
771 Prospective and rigorous testing of the ability to distinguish between recurrent hepatitis C and acute and chronic rejection during a tolerance induction trial (2003) (0)
Liver transplantation in HIV-seropositive individuals [11] (2006) (0)
Diagnosis and management of biliary tract complications after liver transplantation (2002) (0)
Endothelin homeostasis during liver transplantation (1995) (0)
Is adult-to-adult living donor liver transplantation a viable option for liver replacement? (2006) (0)
TACROLIMUS IS EFFECTIVE AND SAFE FOR RESCUE IN BOTH "LOW RISK" AND "HIGH RISK" PATIENTS (1998) (0)
Projection from humoral rejection by a xenografted liver (1994) (0)
Halted Growth of National Kidney Volume in the United States Is Associated with Quality Oversight: 2260 (2012) (0)
Longitudinal study of cryptococcosis in adult solid-organ transplant recipients (2003) (0)
CO-TRANSPLANT WITH ACTIVATED HEPATIC STELLATE CELLS PREVENTS ISLET ALLOGRAFT REJECTION (2004) (0)
IN VIVO DIFFERENTIATION OF TOLEROGENIC DENDRITIC CELLS IN THE LIVER, AN INSIGHT INTO HEPATIC TOLERANCE (2004) (0)
F actors Associated with the Development of Candidemia and Candidemia-Related Death Among Liver Transplant Recipients (2010) (0)
Monitoring immune reactivity in bone marrow augmented kidney recipients (1994) (0)
Hepatic Stellate Cells Promote Generation of MDSC From iPS Cells.: Abstract# A554 (2014) (0)
PD-1 LIGATION MEDIATES INHIBITION OF T CELL RESPONSES BY HEPATIC STELLATE CELLS (2004) (0)
ACTIVATED T CELL APOPTOSIS INDUCED BY HEPATOCYTES AND LIVER NON-PARENCHYMAL CELL IS CASPASE DEPENDENT (1999) (0)
Recipient Age Modulates Effect of Donor Risk On Graft Loss in Deceased Donor Liver Transplantation.: Abstract# B1079 (2014) (0)
CONCURRENT SESSION 96: CLINICAL AND EXPERIMENTAL ISLET TRANSPLANTATION II (2006) (0)
Renal Transplantation in Patients with Prior Thoracic Organ Transplants (1998) (0)
131Under cyclosporine and tacrolimus rate of post transplant lymphoproliferative disorders (PTLD) in children, 766 consecutive recipients: 15 Years experience (2000) (0)
Bacteremia After Liver Transplantation; Few Issues in Selection of Antibiotics for Treatment and Prophylaxis (1993) (0)
Role of Stearoyl-CoA Desaturase (SCD), Key Enzyme in Obesity, in Development of Human Hepatocellular Carcinoma (HCC): Is HCC Expected to Rise With Obesity Epidemic? (2013) (0)
INHIBITION OF T CELL RESPONSES BY HEPATIC STELLATE CELLS, A MECHANISM OF HEPATIC TOLERANCE (2004) (0)
ACCELERATED RE ] ECnON OF LNER GRAFTS WITH PARTICULAR ATIENTION TO FK 506 (2010) (0)
The key determinants of donor lymphoid chimerism support the diagnosis of acute graft versus host disease after liver transplant and predict the clinical outcome (2015) (0)
CHRONIC vmAL HEPATITIS IN RENAL TRANSPLANT RECIPIENTS WITH ALLOGRAFTS FUNCTIONING FOR MORE THAN 20 YEARS (2010) (0)
Free Paper Session II (2006) (0)
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma Associated with Tumor Thrombus (2015) (0)
INDUCTION OF DONOR-SPECIFIC T CELL HYPORESPONSIVENESS BY RECIPIENT-DERIVED ENDRITIC CELLS (2004) (0)
DUAL BLOCKADE OF STAT4 AND NF-&kgr;B PATHWAYS ENHANCES DENDRITIC CELL TOLEROGENICITY (2004) (0)
Analyzing the impact of covid-19 in the hospitalized cohort of liver transplant recipients: An early systematic review and meta-analysis (2021) (0)
Effect of Telaprevir on the Pharmacokinetics of Tacrolimus in the Treatment of Hepatitis C After Liver Transplantation Presidential Poster: 429 (2012) (0)
Long term effect of Interferon-∝ for HCV infection in post-liver transplantation: actual 7 to 9 years follow-up. (1999) (0)
TRANSIENT ISCHEMIA/REPERFUSION INJURY INDUCES CHRONIC MORPHOLOGICAL ALTERATIONS IN THE SMALL BOWEL (1998) (0)
264 LIVER TRANSPLANTATION IN THE UNITED STATES IN THE DIRECT-ACTING ANTIVIRAL ERA: PROFOUND CHANGES IN INDICATIONS, DEMOGRAPHICS, AND PRETRANSPLANT COMORBIDITIES (2020) (0)
Thomas Earl Starzl, MD, PhD, Transplant Pioneer, Polymath, Mentor, March 11th, 1926-March 4th, 2017. (2017) (0)
Migration Pattern of Systemic Administered Myeloid-Derived Suppressor Cells (MDSC) that Protect Islet Allografts from Rejection: 1318 (2012) (0)
The Sky Is Not Falling (2021) (0)
THE ROLE OF MHC CLASS I AND CD8+ T CELLS IN THE PATHOGENESIS OF CHRONIC REJECTION.: Abstract# 925 Poster Board #‐Session: P182‐III (2000) (0)
CD6 is a novel positive regulator of natural antibody producing B-1a cells (INC1P.401) (2015) (0)
GENETIC ENGINEERING OF IMMATURE DENDRITIC CELLS TO EXPRESS MAMMALIAN IL-10 ENHANCES THEIR IMMUNOGENICITY (1998) (0)
Multicenter Results of Stereotactic Body Radiotherapy (SBRT) for Secondary Tumors of the Liver (2011) (0)
Understanding and preventing late graft loss. (2000) (0)
THE EPIDEMIOLOGY OF CRYPTOCOCCAL INFECTION IN SOLID ORGAN TRANSPLANTATION (1999) (0)
Volume 6 index (2004) (0)
Role of liver transplantation in the management of colorectal liver metastases: Challenges and opportunities (2021) (0)
Elimination of Activated T Cells Is Pre-Condition for Immune Suppressor Cells to Induce Transplant Tolerance.: Abstract# 2142 (2014) (0)
LONG TERM RESULTS OF PROTOCOLIZED WITHDRAWAL OF IMMUNOSUPPRESSION (IS) AFTER LIVER TRANSPLANTATION (LTX).: Abstract# 29 (2000) (0)
OUTCOME OF NON‐HEART BEATING DONOR LIVER ALLOGRAFTS TO EXPAND THE DONOR POOL.: Abstract# 985 (2000) (0)
Quantifying the Antigenic Skin Component Accompanying Concomitant Face and Upper Extremity Allotransplantation (2010) (0)
Hepatitis C Related Glomerulonephritis: A Growing Cause of Renal Failure After Liver Transplantation (1998) (0)
INVOLVMENTS OF ICAM‐1 AND HEPATIC LECTIN IN HEPATOCYTE‐INDUCED APOPTOSIS OF ACTIVATED T CELLS: A MECHANISM OF LIVER TRANSPLANT TOLERANCE.: Abstract# 712 (2000) (0)
Early Infectious Complications Post Total Pancreatectomy with Islet Autotransplantation (2018) (0)
Changes in CYP450 enzyme activity over time following liver transplantation (2005) (0)
Chronic Liver Allograft Rejection Increased Expression of p 21 WAFlICipl as a Disease Marker and the Influence of Immunosuppressive Drugs (2010) (0)
Donor-Specific Tolerance in Mouse Liver Transplantation (1998) (0)
CAUSES OF RETRANSPLANTATION, RATE AND SURVIVAL AFTER 4000 CONSECUTIVE PRIMARY LIVER TRANSPLANTATIONS FROM A SINGLE CENTER WITH 15 YEARS MEDIAN FOLLOWUP.: Abstract# 800 Poster Board #‐Session: P57‐III (2000) (0)
BLOCKADE OF THE CD28/B7 PATHWAY IS REQUIRED FOR THE ESTABLISHMENT OF DONOR CELL CHIMERISM IN CD40L‐/‐ RECIPIENTS.: Abstract# 656 (2000) (0)
Early experience with FK 506 in liver transplantation (1991) (0)
PANCREATIC TRANSPLANTATION IN ABDOMINAL VISCERAL RECIPIENTS: INDICATIONS, IMMUNOGENICITY AND FUNCTIONAL OUTCOME (2004) (0)
Orthotopic liver transplantation in U.S. veterans under primary tacrolimus immunosupression. (1996) (0)
Deceased Donor Management (2014) (0)
Efficacy and Safety of Everolimus with Early Reduction or Elimination of Tacrolimus in 719 d e Novo Liver Transplant Recipients - Results at 12 Months: 1556 (2012) (0)
Perioperative fatal pulmonary embolism in a pediatric liver transplant recipient (2021) (0)
Andrés Blei in memoriam (2009) (0)
Influence of donor brief cardiopulmonary arrest on postoperative graft outcome in human liver transplantation: Possible role of ischemic preconditioning (2000) (0)
Print and Media Review (2010) (0)
Chapter 7 Overview of FK 506 in transplantation (2010) (0)
PREVENTION OF ISLET ALLOGARFTS BY CO-TRANSPLANTED HEPATIC STELLATE CELLS IS MEDIATED BY TREG CELL LOCAL EXPANSION: 768 (2008) (0)
Liver Tissue Cells Inhibit Immune Responses by Inducing T Cell Apoptosis: An Application in Islet Transplantation (2007) (0)
EFFECT OF HLA MISMATCH IN AFRICAN-AMERICANS 1 (2010) (0)
INSIGHTS INTO THE INTERACTION OF TISSUE CELLS WITH INFILTRATING CD8+ T CELLS IN LIVER TRANSPLANT TOLERANCE USING A TCR TRANSGENE APPROACH: 870 (2008) (0)
Obituary of Thomas E. Starzl, MD, PhD. (2017) (0)
Hepatic artery (HA) vasospasm in the small-for-size liver graft syndrome (SFSS) is independent of norepinephrine (NE) (2008) (0)
TACROLIMUS FOR PRIMARY LIVER TRANSPLANTATION (LTX) 12 TO 15 YEARS ACTUAL FOLLOW UP IN 1000 CONSECUTIVE PATIENTS WITH SAFETY PROFILE (2004) (0)
49-P : MULTI-SUBSET DONOR LYMPHOID CHIMERISM PATTERNS DURING ACUTE GRAFT VERSUS HOST DISEASE AFTER LIVER TRANSPLANT (2013) (0)
M1644 Oncologic Outcome After Laparoscopic Resection of Malignant Liver Tumors (2010) (0)
Immunosuppression: What's to come! HSCT in Eastern Mediterranean Region (2013) (0)
DISTURBANCES OF ACID-BASE BALANCE FOLLOWING DISCORDANT GUINEA PIG??? RAT LIVER XENOTRANSPLANTATION (1998) (0)
The Liver Transplant Procedure (2011) (0)
IS-2-3 Retro-duodenal reno-portal anastomosis in liver transplantation : Safe approach to portal vein thrombosis(IS-2 International Session (2) Liver transplantation) (2014) (0)
LONG TERM IMPACT OF POSITIVE CROSSMATCH DUE TO IgG VERSUS IgM ANTIBODIES IN PRIMARY LIVER TRANSPLANTATION UNDER TACROLIMUS (1999) (0)
KIDNEY TRANSPLANTATION FOR END STAGE RENAL FAILURE IN LIVER TRANSPLANT RECIPIENTS CARRIERS OF HEPATITIS C VIRUS. (1998) (0)
Venous-right atrial bypass for superior vena cava stenosis during orthotopic liver transplant (1997) (0)
NO EVIDENCE OF TRANSMISSION OF PORCINE ENDOGENOUS RETROVITUS (PERV) INTO PATIENTS WITH END‐STAGE LIVER FAILURE SUBJECTED TO HEMOPERFUSION USING AN EXTRACORPOREAL BIOARTIFICIAL LIVER SUPPORT SYSTEM (BLSS).: Abstract# 1131 (2000) (0)
Hepatitis C virus and renal failure. (2003) (0)
Tacrolimus ( FK 506 ) and the Pharmaceuticall Academid Regulatory Gauntlet (2010) (0)
THE PATHOPHYSIOLOGY ASSOCIATED WITH SMALL-FOR-SIZE LIVER GRAFTS (2004) (0)
Non-MHC restriction in the protection from humoral rejection given by a hepatic xenograft (1994) (0)
THE USE OF MHC CLASS II-DEFICIENT MICE TO DETERMINE THE ROLE OF DIRECT VS INDIRECT ANTIGEN PRESENTATION IN THE PATHOGENESIS OF CHRONIC REJECTION (1998) (0)
THE AVOIDANCE OF FORSSMAN-LIKE REACTION IN HAMSTERS RECEIVING RAT ANTISERUM IS DUE TO ACCOMMODATION TO HETEROLOGOUS COMPLEMENT (1999) (0)
Erratum: Tobacco use following liver transplantation for alcoholic liver disease: An underestimated problem (Liver Transplantation (2005) vol. 11 (6) (679-683)) (2005) (0)
SYSTEMIC, NOT LOCAL, ADMINISTRATION OF LIVER-DERIVED DC INDUCE DONOR-SPECIFIC HYPORESPONSIVENESS ASSOCIATED WITH INCREASED CD4+ AND GR-1+ CELLS IN ALLOGRAFTS (1999) (0)
INTESTINAL TRANSPLANTATION IN CHILDREN – 5 YEAR EXPERIENCE (1995) (0)
Peri-operative Reparixin therapy resulted in 50% 5-year insulin independence rate: The University of Chicago experience. (2023) (0)
CTLA4Ig ENHANCES THE INCIDENCE OF XENOGENEIC BONE MARROW ENGRAFTMENT AND ALTERS THE CLINICAL PRESENTATION OF GRAFT-VERSUS-HOST DISEASE (1999) (0)
Should reimbursement be denied for liver transplantation in patients with hepatocellular carcinoma? (1997) (0)
External Validity in Solid Organ Transplantation Research: Are Ethical Practices Compromised?: 2255 (2012) (0)
Serum cholesterol levels in African Americans after renal transplantation under FK 506 immunosuppression. (1993) (0)
Experience with liver and kidney allograft from non-heart-beating donors. Discussion (1995) (0)
105Tacrolimus offer virtual freedom from chronic rejection after Primary Liver Transplantation (LTX): Review of 5252 biopsies in 1055 LTX, mean followup-6 years (2000) (0)
TOLEROGENIC ACTIVITY OF LIVER DENDRITIC CELLS IS REGULATED BY TLR4/B7-H1 PATHWAY. (2006) (0)
MECHANISTIC INSIGHTS: LONG-TERM ALLOGRAFT SURVIVAL BY ADMINISTRATION OF IMMATURE DENDRITIC CELLS AND SUBDOSING SIROLIMUS (2004) (0)
CONDITIONS ASSOCIATED WITH POST-OPERATIVE LEUKOCYTOSIS FOLLOWING SIMULTANEOUS PANCREAS AND KIDNEY (SPK) TRANSPLANTATION.: 0110 (2003) (0)
Su1692 Post Liver Transplantation Sarcopenia in Cirrhosis: Mechanisms and Prospective Evaluation (2013) (0)
PROLONGED SURVIVAL OF HEART ALLOGRAFTS TRANSFECTED WITH GENES ENCODING CTLA4Ig USING RCOMBINANT ADENO‐ASSOCIATED VIRUS VECTORS.: Abstract# 644 (2000) (0)
215 Hepatic stellate cells regulate immune responses by induction of activated T cells apoptosis (2003) (0)
REPLY TO "COMMENT ON PREGNANCY AFTER LIVER TRANSPLANTATION UNDER TACROLIMUS" (1998) (0)
Study of HCV genotype and histopathology on post-transplant recurrent hepatitis C (2004) (0)
112Causes of retransplantation FTER 4000 consecutive primary liver transplantations from a single center with 15 years median followup rate and survival (2000) (0)
Efficacy and Safety of Everolimus Based Immunosuppression in HCV Positive De Novo Liver Transplant Recipients (2012) (0)
Nosocomial bactermia in the immediate post-operative course after liver transplantation (1993) (0)
SYSTEMIC TREATMENT WITH ANTISENSE OLIGODEOXYRIBONUCLEOTIDES TARGETING NF‐&kgr;B mRNA SIGNIFICANTLY PROLONGS ALLOGRAFT SURVIVAL BY SUPPRESSION OF CYTOTOXIC ACTIVITY.: Abstract# 651 (2000) (0)
IgG lymphocytotoxic antibodies in clinical liver transplantation: Studies toward further defining their significance (1995) (0)
Long-Term Follow-Up of Patients with Primary Sclerosing Cholangitis Undergoing Liver Transplantation with Duct-to-Duct Biliary (2018) (0)
T CELL APOPTOSIS INDUCED BY LIVER B220+ DENDRITIC CELLS: A MECHNISTIC INSIGHT (2004) (0)
myeloid-derived suppressor cells The role of complement component 3 (C3) in differentiation of (2014) (0)
178B: A NOVEL CADAVER STUDY QUANTIFYING THE POTENTIAL ANTIGENIC SKIN COMPONENT ACCOMPANYING CONCOMITANT FACE AND UPPER EXTREMITY TRANSPLANTATION (2010) (0)
INTESTINAL TRANSPLANTATION AND END STAGE GASTROINTESTINAL DISEASE: IMPROVED OUTCOME AND COST EFFECTIVENESS (1999) (0)
S.134. IFN-γ-dependent Immune Regulation is Mediated by Organ Stromal Cells (2009) (0)
CONCOMITANT INFUSION OF DONOR BONE MARROW TO ESTABLISH CHIMERISM AND TOLERANCE DOES NOT INCREASE THE RISK OF EBV ASSOCIATED LYMPHOMAS IN ORGAN ALLOGRAFT RECIPIENTS.: Abstract# 124 (2000) (0)
MECHANISTIC INSIGHT INTO INDUCTION OF MEDIATING GENERATION OF MYELOID-DERIVED SUPPRESSOR CELLS BY LIVER STROMAL CELLS: 2499 (2010) (0)
Repertoire, memory subsets, and function of EBV-specific CD8+T cells in peripheral blood from stable solid organ transplant patients (2003) (0)
ABDOMINAL MULTIVISCERAL TRANSPLANTATION1,2 (2010) (0)
COMMENT ON : PREGNANCY AFTER LIVER TRANSPLANTATION UNDER TACROLIMUS. AUTHORS' REPLY (1998) (0)
Myeloid Suppressor Cells Protect Islet Allografts through iNOS-Mediated T Cell Inhibition: 1942 (2012) (0)
TREATMENT OF HEPATIC FAILURE WITH ADVANCED ENCEPHALOPATHY USING THE BIOLOGIC-DT: PRELIMINARY CLINICAL RESULTS (1998) (0)
Liver Stromal Cells Contribute to Liver Transplant Tolerance: Involved Cellular and Molecular Mechanisms: 1833 (2012) (0)
LIVERS TRANSPLANTED FROM DONORS AFTER CARDIAC DEATH WITH DEATH OCCURRING IN EITHER THE ICU OR THE OPERATING ROOM HAVE EXCELLENT OUTCOMES. (2004) (0)
Steroid withdrawal in tacrolimus-based immunosuppression after liver transplantation: long-term results of Pittsburgh Group (2004) (0)
46-W: Donor lymphoid chimerism kinetics in a successfully treated case of acute graft versus host disease after orthotopic liver transplantation (2008) (0)
THE NOVEL USE OF AUTOLOGOUS DENDRITIC CELLS LOADED WITH APOPTOTIC LCL FOR EX VIVO GENERATION OF SPECIFIC CTL FROM THE PBMC OF EBV INDIVIDUALS.: Abstract# 629 (2000) (0)
FK 506 in small bowel transplant recipients (1994) (0)
104Long term results of protocolized withdrawal of immunosuppression after liver transplantation (2000) (0)
Herniated Umbilical Varix in a Patient With Cirrhosis (2019) (0)
In Memoriam: The Contributions of Thomas Earl Starzl, MD, PhD (1926–2017) (2017) (0)
Efficacy and safety of everolimus in de novo liver transplant recipients - 12 month results of a randomized multicenter study. O-80 (2012) (0)
The natural history of Barrett's esophagus (BE) in orthotopic liver transplant (OLT) recipients (2000) (0)
Normothermic Ex-Vivo Perfusion of the Intestine: the introduction of an innovative physiologic model with novel biomarkers (2017) (0)
Cellular immunotherapy for post-transplant lympho-proliferative disease (PTLD) using recipeint's lymphokine activated killer (LAK) cells generated Ex-Vivo (1996) (0)
An attempt to induce tolerance with infusion of donor bone marrow in organ allograft recipients (1996) (0)
Efficacy of everolimus in 719 liver transplant recipients: a randomized, controlled study (2012) (0)
Conversion from Tacrolimus to Cyclosporine A Following Primary Liver Transplantation Under Tacrolimus (1999) (0)
Brain Abscesses in Liver Transplant Recipients: Prospective, Multicenter Study with Implications for Management. (1998) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With John Julian Fung?

John Julian Fung is affiliated with the following schools:

John Julian Fung's Academic­Influence.com Rankings

Why Is John Julian Fung Influential?

John Julian Fung's Published Works

Published Works

What Schools Are Affiliated With John Julian Fung?

John Julian Fung's AcademicInfluence.com Rankings